clofibrate has been researched along with Hyperlipemia in 632 studies
angiokapsul: contains clofibrate & insoitolnicotinate
| Excerpt | Relevance | Reference |
|---|---|---|
| "The possibility that hyperlipidemia and an increase of mononuclear cells in the glomeruli could participate in the pathogenesis of minimal change glomerulopathy was evaluated in puromycin aminonucleoside (PAN) nephrosis in rats." | 7.69 | The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats. ( Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y, 1996) |
| "The effect of long-term treatment over 40 weeks with Bezafibrate on lipids and lipoproteins was investigated in 27 patients with primary hyperlipoproteinemias (hlp) (12 patients with hlp type IV, 7 patients with type IIb, 3 patients with type IIa, 4 patients with type V and 1 patient with type III)." | 7.66 | [Bezafibrate in primary hyperlipidemias (author's transl)]. ( Bode, G; Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG, 1982) |
| "The effect of clofibrate on the same subjects in similar test conditions were used as a control to verify the alleged beneficial effects from garlic and onion on alimentary hyperlipemia in normals and in cases with ischemic heart disease." | 7.66 | Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia. ( Arora, RC; Arora, S, 1981) |
| "In a randomised blind study with 404 patients 1 capsule Etofibrate per day (500 mg) in sustained release dosage form was tested in comparison to other lipid-lowering drugs." | 6.65 | [An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations]. ( Füsgen, I; Summa, JD, 1980) |
| "Probucol is shown to be a better accelerator for lipid clearance in triton hyperlipidemia than clofibrate." | 5.27 | Effect of probucol on triton induced hyperlipidemias in CFY rats. ( Krishnamurthy, A; Shridhar, DR; Thapar, GS, 1985) |
| "It was shown that in patients with breast cancer and cancer of the corpus uteri in the presence of hypercholesterinemia and hypertriglyceridemia the level of blood somatomedin activity would be 3--5 times the control values, being 3." | 5.26 | [Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer]. ( Bershteĭn, LM; Dil'man, VM; Ostroumova, MN; Vasil'eva, IA, 1980) |
| "The effect of essential phospholipids in combination with Clofibrate (N 041) was compared with that of Clofibrate alone in a double blind study in 96 patients with hypertriglyceridemia and/or hypercholesterolemia." | 5.04 | [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate]. ( Gaertner, U; Johannes, KJ, 1976) |
| "Oxidative stress and inflammation have been considered the main factors in the liver injury of clofibrate (CF)." | 4.02 | The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity. ( Cheng, L; Guo, M; He, Y; Jiang, H; Liu, J; Ren, C; Shi, Y; Sun, M; Wang, B; Wang, W; Wang, X; Xie, Y; Xu, X, 2021) |
| "The possibility that hyperlipidemia and an increase of mononuclear cells in the glomeruli could participate in the pathogenesis of minimal change glomerulopathy was evaluated in puromycin aminonucleoside (PAN) nephrosis in rats." | 3.69 | The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats. ( Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y, 1996) |
| "The dementia of a patient with hyperlipidemia improved dramatically on treatment with diet and fenofibrate." | 3.67 | Hyperlipidemic dementia. ( Agar, N; Bousser, MG; Lacombe, C; Mas, JL, 1985) |
| "The effect of long-term treatment over 40 weeks with Bezafibrate on lipids and lipoproteins was investigated in 27 patients with primary hyperlipoproteinemias (hlp) (12 patients with hlp type IV, 7 patients with type IIb, 3 patients with type IIa, 4 patients with type V and 1 patient with type III)." | 3.66 | [Bezafibrate in primary hyperlipidemias (author's transl)]. ( Bode, G; Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG, 1982) |
| " In the hyperlipemia induced in rats by feeding a high cholesterol diet, Y-9738 [ethyl 2(4-chlorophenyl)-5-ethoxy-4-oxazoleacetate] produced a dose-dependent reduction of serum cholesterol: such hypolipidemic activity was estimated to be about 7 times as great as that of clofibrate." | 3.66 | Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent. ( Kobayakawa, T; Osuga, K; Yasuda, H, 1978) |
| "A 16 days clofibride treatment in hyperlipaemic rabbit (fat supply), reduces hypertriglyceridemia and hypercholesterolemia." | 3.66 | [Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits]. ( Benouniche, N; Drif, M; Elsair, J; Ghouini, A; Iklef, F; Khelfat, K; Marquie, G; Tabet Aoul, FS; Tabet Aoul, M, 1982) |
| " In addition, KF1492 produced significant reductions of s-CL and s-TG in thiouracil-fed rats and decreasing phase of Triton-induced hyperlipemia of rats." | 3.66 | Lipid-lowering effects of N-[4-methylbenzylthiocarbonyl]-L-phenylalanine (KF1492), a new phenylalanine derivative. ( Kojima, T; Marumo, H; Shuto, K; Tanaka, M; Yamada, K, 1982) |
| "The effect of clofibrate on the same subjects in similar test conditions were used as a control to verify the alleged beneficial effects from garlic and onion on alimentary hyperlipemia in normals and in cases with ischemic heart disease." | 3.66 | Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia. ( Arora, RC; Arora, S, 1981) |
| "Clofibric acid (p-chlorophenoxyisobutyric acid), the major metabolite of Clofibrate, a drug used in the treatment of hyperlipemia, was assayed in blood serum using an ultraviolet absorbance monitor as a gas-liquid chromatographic detector." | 3.66 | Therapeutic drug assays with gas-liquid chromatography and optical detection. ( Karmen, A; Lam, S; Pritchett, T, 1981) |
| "70 patients with hyperlipemias of various types were treated perorally with 350 mg Mg-chlorophenoxyisobutyrate, and 250 mg of mesoinositol-hexanicotinate (Atroplex) three times daily." | 3.65 | [Clinical study with a new antihyperlipemic combination]. ( Pistautz, H, 1977) |
| "Nine subjects with asymptomatic hyperlipidemia, hyperfibrinogenemia and exercise ST segment depressions were treated with clofibrate in order to lower plasma fibrinogen and serum lipids." | 2.65 | Effect of blood viscosity decrease on exercise ST segment depressions in hyperlipidemia. ( Blombäck, M; Ekelund, LG; Olsson, AG, 1980) |
| "Twenty-two patients suffering from hyperlipidemia and receiving therapy consisting of a lipid-lowering diet and clofibrate (1 g X 2) were in addition given colestipol hydrochloride (5 g X 3) (Colestid, Upjohn) in a randomized, cross-over study for 2 periods of 6 weeks." | 2.65 | The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies. ( Boberg, J; Hellsing, K; Lithell, H; Vessby, B, 1980) |
| "Bezafibrate treatment resulted in significant decrease in the serum concentrations of triglycerides, total cholesterol and LDL-cholesterol, whereas HDL-cholesterol serum levels increased." | 2.65 | Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients. ( Grützmacher, P; Lang, W; Scheuermann, E, 1981) |
| "In a randomised blind study with 404 patients 1 capsule Etofibrate per day (500 mg) in sustained release dosage form was tested in comparison to other lipid-lowering drugs." | 2.65 | [An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations]. ( Füsgen, I; Summa, JD, 1980) |
| " The patients were divided into two groups at random and in each case received 3 X 50, 3 X 100, 3 X 150 and 3 X 200 mg bezafibrate daily in increasing or falling dosage for four weeks." | 2.65 | [Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)]. ( Adam, O; Lang, PD; Wolfram, G; Zöllner, N, 1979) |
| "Uric acid was significantly reduced only during the first period of treatment (p less than 0." | 2.64 | Clofibrate in type II hyperlipoproteinemia. ( Bang, HO; Ditzel, J, 1976) |
| "Fibrinogen concentration was slightly but statistically not significantly decreased." | 2.64 | [Oral anticoagulants and platelet function in hypolipemic therapy using a new clofibrate analog (BM 15.075) (author's transl)]. ( Andrassy, K; Barth, P; Ehlers, W; Hoffrichter, A; Lang, PD; Schlierf, G; Walter, E; Weber, E; Zimmermann, R, 1977) |
| "of clofibrate was studied in 29 subjects with different types of hyperlipoproteinaemia in a single blind crossover fashion." | 2.64 | Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia. ( Carlson, LA; Lang, PD; Olsson, AG; Rössner, S; Walldius, G, 1977) |
| "Clofibrate and m-Inositolnicotinate in a daily dosage of 1,5 g Clofibrate and 1,2 g m-Inositolnicotinate during long term treatment effected a good triglyceride fall in all three lipoprotein fractions, especially in VLDL." | 2.64 | [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)]. ( Schwartzkopff, W; Zschiedrich, M, 1978) |
| "Halofenate is a new antilipemic drug which is an ester of carboxylic acid." | 2.64 | The metabolic spectrum of halofenate. ( Ryan, JR, 1975) |
| "When clofibrate was added, a further decrease of plasma cholesterol by 6% was observed, and the levels of triglycerides were reduced." | 2.64 | Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids. ( Blomhoff, JP; Fausa, O; Gjone, E; Lanner, A; Ritland, S; Skrede, S, 1975) |
| "Metabolic syndrome is associated with increased cardiovascular risk." | 2.41 | [Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome]. ( Idzior-Waluś, B, 2001) |
| "Several forms of dyslipidemia are associated with premature coronary artery disease (CAD) and other vascular disease." | 2.39 | Hyperlipidemia: perspectives in diagnosis and treatment. ( Gotto, AM; Yeshurun, D, 1995) |
| "Fibric acid derivatives may interact with other drugs and the interactions can be of clinical relevance." | 2.39 | Drug interactions with fibric acids. ( Dujovne, CA; Lozada, A, 1994) |
| "Hyperlipidemia should be managed systematically using information about the association between increased lipid concentrations and CAD, patient risk factors, and limitations of both diet and drug therapy." | 2.37 | Contemporary recommendations for evaluating and treating hyperlipidemia. ( Perry, RS, 1986) |
| "The early stage of diabetic nephropathy (DN) is linked to proteinuria." | 1.35 | Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy. ( Chang, HH; Inscho, EW; Luo, P; Seki, T; Wang, CY; Wang, MH; Zhang, J; Zhou, Y, 2009) |
| "In 17 patients with primary mixed hyperlipidemia we studied levels and composition of lipoproteins in fasting plasma, lipoprotein-modifying enzymes, and postprandial lipoprotein metabolism after an oral fat-tolerance test supplemented with vitamin A before, and 12 weeks after treatment with etophylline clofibrate." | 1.29 | Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition. ( Föger, B; Hopferwieser, T; Lechleitner, M; Menzel, HJ; Patsch, JR; Pfeiffer, KP; Ritsch, A; Tröbinger, G; Utermann, G, 1995) |
| " Basal levels of plasma progesterone, corticosterone, aldosterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, dehydroepiandrosterone sulphate and dehydroepiandrosterone, and their response to ACTH 1 mg im, were not reduced by chronic administration of clofibrate 2 g per day p." | 1.28 | Lack of effect in vivo of clofibrate on adrenal steroid secretion. ( Auzeby, A; Bogdan, A; Heshmati, HM; Nahoul, K; Roger, M; Touitou, Y; Turpin, G; Varsaux, J, 1989) |
| " It is demonstrated that propylthiouracil-induced hypothyroid-hyperlipidemic chick develops severe toxic manifestations following clofibrate administration." | 1.27 | Propylthiouracil-induced hypothyroid hyperlipidemic chick: a model for clofibrate-induced toxicity. ( Cho, C; Linscheer, WG; Raheja, KL, 1986) |
| "Probucol has a sustained effect, additive to that of a lipid-lowering diet; it can reduce total serum cholesterol and cause xanthoma regression even in patients with receptor-defective homozygous familial hypercholesterolemia." | 1.27 | Medical management of hyperlipidemia and the role of probucol. ( Davignon, J, 1986) |
| " Adverse side effects ranging from mere annoyances to uncommon serious consequences may be associated with dietary modification, recreational physical exercise, and drug intervention." | 1.27 | Adverse effects of the treatment for hyperlipidemia. ( Malinow, MR, 1986) |
| "Oral carnitine has been reported to have a lipid-lowering effect with concomitant elevation of high density lipoprotein cholesterol (HDL-C) levels in normo- and hyperlipidemic individuals." | 1.27 | Plasma carnitine and lipid-lowering drugs. ( Davignon, J; Nestruck, AC; Pande, SV, 1985) |
| "Probucol is shown to be a better accelerator for lipid clearance in triton hyperlipidemia than clofibrate." | 1.27 | Effect of probucol on triton induced hyperlipidemias in CFY rats. ( Krishnamurthy, A; Shridhar, DR; Thapar, GS, 1985) |
| "Experimental hyperlipidemia was induced in ddY, C57BL, BALB and ICR strain mice and in Wistar rats." | 1.27 | [Strains and species differences in experimental hyperlipidemia]. ( Hirai, Y; Kawakami, M; Koyama, S; Mishima, Y; Mizutani, A; Morishita, S; Saito, T, 1986) |
| "It is concluded that clofibrate treatment of hyperlipidemia in uremic patients, when carefully monitored, is safe and efficacious." | 1.26 | Clofibrate treatment of hyperlipidemia in chronic renal failure. ( Boulu, R; Crosnier, J; di Giulio, S; Drüeke, T; Nicolaĭ, A; Zingraff, J, 1977) |
| "She developed eruptive xanthomata with a grossly raised serum triglyceride concentration and chylomicronaemia when pregnant and also when taking a combined oral contraceptive pill containing 50 microgram of oestrogen." | 1.26 | The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern. ( McLintock, D; Muller, DP; Pavlou, C; Whitelaw, AG, 1978) |
| " All patients were dietary adapted before the preliminary wash-out period of 4 weeks and received etofylline clofibrate in a dosage of 500 mg/day (2x1 capsule) over 4 weeks, and 750 mg/day (3 x 1 capsule) over further 4 months." | 1.26 | [Clinical effects and tolerance of etofylline clofibrate]. ( Metz, G; Specker, M; Ziegler, WJ, 1980) |
| " Under the same experimental conditions clofibrate presents a poor dose-response correlation on plasma lipids and generally appears at least 10 times less active than LR 19731 on cholesterol but more effective on liver weight." | 1.26 | Metabolic disorders associated with hyperlipemia: activity of an extremely potent hypolipemic agent (LR 19731). ( Fregnan, GB; Frigerio, L; Porta, R, 1981) |
| "Hyperlipemia is one of several risk factors for premature ischemic vascular disease." | 1.26 | A pathophysiologic approach to managing hyperlipemia. ( Hazzard, WR, 1976) |
| "Treatment of hyperlipidemia is aimed at reducing the risk of atherosclerosis or arresting its course." | 1.26 | Therapy of the hyperlipidemias. ( Lees, AM; Lees, RS, 1976) |
| " Eight of the patients had moderately impaired renal function, with a creatinine clearance between 20 and 40 ml/min; the mean plasma half-life of bezafibrate in them was 7." | 1.26 | Clinical pharmacokinetics of bezafibrate in patients with impaired renal function. ( Anderson, P; Norbeck, HE, 1981) |
| "The most frequent indication for treatment of hyperlipidemia is for prevention of arteriosclerosis, a suspected but unproved benefit." | 1.26 | Drug treatment of hyperlipidemia. ( Gotto, AM; Yeshurun, D, 1976) |
| "The hyperlipidemia was induced by intraperitoneal injection of Triton WR-1339." | 1.26 | Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model. ( Loh, W; Newman, HA; Poochikian, GK; Sankarappa, SK; Witiak, DT, 1976) |
| "It was shown that in patients with breast cancer and cancer of the corpus uteri in the presence of hypercholesterinemia and hypertriglyceridemia the level of blood somatomedin activity would be 3--5 times the control values, being 3." | 1.26 | [Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer]. ( Bershteĭn, LM; Dil'man, VM; Ostroumova, MN; Vasil'eva, IA, 1980) |
| "Headaches were associated with vertigo, paresis and paresthesia of the limbs and loss of consciousness in some instances." | 1.26 | Intermittent cerebral symptoms in type V hyperlipoproteinemia. ( Harcos, P; Márkus, A; Péter, A; Pucsok, J, 1976) |
| "Clofibrate was effective in all animal models, but the spirolactone 4 exhibited antitriglyceridemic activity only in the Triton model." | 1.26 | Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one. ( Baldwin, JR; Cavestri, RC; Feller, DR; Newman, HA; Sober, CL; Witiak, DT, 1978) |
| "A family with familial combined hyperlipidemia (multiple-lipoprotein type hyperlipidemia) was investigated with regard to mode of inheritance, phenotypic expression, presence of genetic markers, and biochemical parameters related to lipid metabolism." | 1.26 | [Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)]. ( Buchmann, P; Göschke, H; Koller, F; Stähelin, HB; Strub, P; Thiel, G, 1976) |
| " Diosgenin did not affect the bioavailability of CPIB." | 1.26 | Combined effects of clofibrate and diosgenin on cholesterol metabolism in rats. ( Cayen, MN; Dvornik, D, 1978) |
| "Ethanol lipemia was totally prevented by the agent at 100 mg/kg." | 1.26 | Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteins. ( Cerutti, S; D'Atri, G; Gomarasca, P; Scolastico, C; Sirtori, CR; Tronconi, G, 1978) |
| "Bezafibrate was well tolerated, hypoglycaemia or hypoglycaemic reactions were not observed." | 1.26 | [Improvement in diabetes control by treatment with bezafibrate]. ( Rüth, E; Vollmar, J, 1982) |
| " The most appropriate drug, clofibrate, is renally excreted and can be used safely if the dosage is markedly reduced." | 1.26 | Uremic hyperlipidemia: the nature of the problem. ( Brunzell, JD; Sherrard, DJ, 1977) |
| "Type V hyperlipemia was often combined with other metabolic syndromes such as diabetes, hyperuricemia or gout, or obesity." | 1.26 | [Type V hyperlipemia. 54 cases (author's transl)]. ( Beaumont, V; Buxtorf, JC; Jacotot, B; Schlesinger, M, 1979) |
| " In hyperlipidemic rats ciprofibrate suppresses the increase in blood lipids 33% at a daily dosage of 0." | 1.26 | The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug. ( Arnold, A; Beyler, AL; McAuliff, JP; Phillips, DK; Powers, LG, 1979) |
| " An individualized dosage of bezafibrate and repeated checks of the serum concentrations of the drug are recommended during long-term treatment of uremic patients." | 1.26 | Treatment of uremic hypertriglyceridaemia with bezafibrate. ( Anderson, P; Norbeck, HE, 1982) |
| "Clofibrate treatment induces a triglyceride reduction (incrementTG) which is correlated with the reduction in the insulin/glucagon molar ration (incrementI/G)." | 1.25 | Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment. ( Assan, R; Crepaldi, G; Fedele, D; Muggeo, M; Tiengo, A, 1975) |
| "Nephrotic mixed hyperlipidemia may be associated with accelerated coronary artery disease." | 1.25 | Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia. ( Edwards, KD; Schapel, GJ, 1975) |
| "It is suggested that chronic renal failure should be regarded as a contraindication to the use of clofibrate for the treatment of any coexisting hyperlipidaemia." | 1.25 | Clofibrate-induced muscle damage in patients with chronic renal failure. ( Alvarez-Ude, F; Kerr, DN; Pierides, AM, 1975) |
| " Nicotinic acid in the form of niceritrol had another type of dose-response in type II with doses from 3 to 6 g/day." | 1.25 | Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. ( Carlson, LA; Olsson, AG; Orö, L; Rössner, S, 1975) |
| "From 30 cases of mixed hyperlipidemia which were resistant to apparently correctly managed treatment, combining an adapted diet and Clofibrate, the authors confirmed that there is no specific clinical or laboratory picture in these cases: except for the constant presence of two beta-lipoproteins, with a high percentage of slow pre-beta, on electrophoresis on agarose, persisting throughout the length of inactive treatment." | 1.25 | [Mixed hyperlipidemia resistant to ordinary dietetic and medical treatment. 30 cases]. ( De Gennes, JL; Lambrozo, J; Truffert, J; Turpin, G, 1975) |
| " This conclusion was strengthened by finding that long-term administration of the drug can cause marked reduction in body pools of cholesterol." | 1.25 | Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. ( Ahrens, EH; Grundy, SM; Nestel, PJ; Salen, G; Schreibman, PH, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 605 (95.73) | 18.7374 |
| 1990's | 15 (2.37) | 18.2507 |
| 2000's | 10 (1.58) | 29.6817 |
| 2010's | 1 (0.16) | 24.3611 |
| 2020's | 1 (0.16) | 2.80 |
| Authors | Studies |
|---|---|
| Witiak, DT | 6 |
| Newman, HA | 6 |
| Poochikian, GK | 2 |
| Fogt, SW | 1 |
| Baldwin, JR | 4 |
| Sober, CL | 3 |
| Feller, DR | 4 |
| Cavestri, RC | 2 |
| Chapman, JM | 1 |
| Voorstad, PJ | 2 |
| Cocolas, GH | 1 |
| Hall, IH | 2 |
| Wyrick, SD | 1 |
| Cocolas, G | 1 |
| Willson, TM | 1 |
| Brown, PJ | 1 |
| Sternbach, DD | 1 |
| Henke, BR | 1 |
| Xie, Y | 1 |
| Liu, J | 1 |
| Shi, Y | 1 |
| Wang, B | 1 |
| Wang, X | 1 |
| Wang, W | 1 |
| Sun, M | 1 |
| Xu, X | 1 |
| Jiang, H | 1 |
| Guo, M | 1 |
| He, Y | 1 |
| Ren, C | 1 |
| Cheng, L | 1 |
| Luo, P | 1 |
| Zhou, Y | 1 |
| Chang, HH | 1 |
| Zhang, J | 1 |
| Seki, T | 1 |
| Wang, CY | 1 |
| Inscho, EW | 1 |
| Wang, MH | 1 |
| Ringseis, R | 1 |
| Keller, J | 1 |
| Lukas, I | 1 |
| Spielmann, J | 1 |
| Most, E | 1 |
| Couturier, A | 1 |
| König, B | 1 |
| Hirche, F | 1 |
| Stangl, GI | 1 |
| Wen, G | 1 |
| Eder, K | 1 |
| OLIVER, MF | 1 |
| ROBERTS, SD | 1 |
| HAYES, D | 1 |
| PANTRIDGE, JF | 1 |
| SUZMAN, MM | 1 |
| BERSOHN, I | 1 |
| PRIOR, IA | 1 |
| CAMPBELL, DG | 1 |
| SHARVILL, DE | 1 |
| BORRIE, P | 2 |
| ENGSTROEM, J | 1 |
| VASTESAEGER, M | 2 |
| GILLOT, P | 1 |
| DELCOURT, R | 1 |
| MISHKEL, MA | 2 |
| STRISOWER, EH | 1 |
| NICHOLS, AV | 1 |
| LINDGREN, FT | 1 |
| SMITH, L | 1 |
| FELT, V | 3 |
| STARKA, L | 1 |
| BEDNAR, J | 2 |
| PEAK, HJ | 1 |
| MITCHELL, AS | 1 |
| JOSE, AD | 1 |
| Fujioka, T | 1 |
| Ueno, T | 1 |
| Matsumoto, T | 1 |
| Watanabe, H | 1 |
| Bloomfield, HE | 1 |
| Adak, M | 1 |
| Gupta, JK | 1 |
| Olsson, AG | 9 |
| Blombäck, M | 1 |
| Ekelund, LG | 1 |
| Elsair, J | 2 |
| Marquie, G | 2 |
| Drif, M | 1 |
| Khelfat, K | 2 |
| Benouniche, N | 1 |
| Tabet Aoul, M | 2 |
| Tabet Aoul, FS | 2 |
| Iklef, F | 2 |
| Ghouini, A | 2 |
| Dahmani, Y | 1 |
| Dufour, P | 1 |
| Miettinen, TA | 4 |
| Kunesová, M | 1 |
| Honková, M | 1 |
| Zeman, M | 1 |
| Mares, P | 1 |
| Skorepa, J | 1 |
| Kesäniemi, YA | 1 |
| Grundy, SM | 6 |
| Pyrig, LA | 1 |
| Petrun, NM | 1 |
| Nikulina, GG | 1 |
| Gorelova, NR | 1 |
| Nash, DT | 1 |
| Scherhag, R | 1 |
| Dixit, VP | 1 |
| Joshi, S | 1 |
| Rüth, E | 1 |
| Vollmar, J | 5 |
| Janka, HU | 1 |
| Standl, A | 1 |
| Holler, HD | 2 |
| Mehnert, H | 1 |
| Lang, PD | 10 |
| Hunninghake, DB | 1 |
| Seri, K | 3 |
| Sato, R | 2 |
| Hamazaki, Y | 1 |
| Yamamoto, T | 1 |
| Ishiyama, N | 1 |
| Mälkönen, M | 4 |
| Muona, M | 1 |
| Manninen, V | 5 |
| Synková, J | 1 |
| Groh, J | 1 |
| Brátová, M | 1 |
| Zahradník, J | 1 |
| Jánská, D | 1 |
| Nicoll, A | 1 |
| Miller, NE | 2 |
| Lewis, B | 4 |
| Lithell, H | 5 |
| Vessby, B | 4 |
| Boberg, J | 5 |
| Hellsing, K | 3 |
| Daubresse, JC | 1 |
| Palmieri, B | 1 |
| Gasparini Casari, M | 1 |
| DiBlasio, P | 1 |
| Zirilli, E | 1 |
| Grützmacher, P | 1 |
| Scheuermann, E | 1 |
| Lang, W | 1 |
| Havel, RJ | 3 |
| Kane, JP | 3 |
| Duffield, RG | 1 |
| Jamieson, CW | 1 |
| Wechsler, JG | 1 |
| Hutt, V | 1 |
| Klör, HU | 1 |
| Bode, G | 1 |
| Ditschuneit, H | 2 |
| Farina, R | 1 |
| Lovati, MR | 1 |
| Raucci, G | 1 |
| Sirtori, CR | 3 |
| Norbeck, HE | 2 |
| Anderson, P | 2 |
| Yamada, K | 1 |
| Shuto, K | 1 |
| Kojima, T | 1 |
| Marumo, H | 1 |
| Tanaka, M | 1 |
| Gustafsson, K | 1 |
| Kiessling, H | 1 |
| Matsuo, T | 2 |
| Taniguchi, T | 1 |
| Amemiya, K | 1 |
| Kudo, M | 1 |
| Saito, G | 1 |
| Kato, T | 2 |
| Sterner, W | 2 |
| Chibanguza, G | 1 |
| Metz, G | 2 |
| Ziegler, WJ | 1 |
| Specker, M | 1 |
| Stratmann, FW | 1 |
| Hofmann, H | 1 |
| Gragnoli, G | 1 |
| Tanganelli, I | 1 |
| Signorini, AM | 1 |
| Kristodhullu, A | 1 |
| Minatelli, JA | 1 |
| Loh, W | 2 |
| Fabbrocini, V | 1 |
| Fregnan, GB | 1 |
| Frigerio, L | 1 |
| Porta, R | 1 |
| Kutz, K | 1 |
| Schulte, A | 1 |
| Arora, RC | 1 |
| Arora, S | 1 |
| Schneider, J | 7 |
| Schulze, J | 3 |
| Julius, U | 1 |
| Hanefeld, M | 5 |
| Haller, H | 2 |
| Leonhardt, W | 3 |
| Hedstrand, H | 3 |
| Gustafsson, IB | 1 |
| Hood, B | 2 |
| de la Fuente, R | 1 |
| Santos, M | 1 |
| Marini, U | 1 |
| Bargiggia, A | 1 |
| Riboli, P | 1 |
| Karmen, A | 2 |
| Pritchett, T | 1 |
| Lam, S | 1 |
| McNamara, DJ | 1 |
| Davidson, NO | 1 |
| Fernandez, S | 1 |
| Cheung, MC | 1 |
| Albers, JJ | 2 |
| Wahl, PW | 1 |
| Hazzard, WR | 4 |
| Rössner, S | 4 |
| Lipovetskiĭ, BM | 1 |
| Triufanov, VF | 1 |
| Konstantinov, VO | 1 |
| Belousova, LV | 1 |
| Samuel, P | 3 |
| Vasil'eva, IA | 1 |
| Bershteĭn, LM | 1 |
| Ostroumova, MN | 1 |
| Dil'man, VM | 1 |
| Revill, J | 1 |
| Füsgen, I | 1 |
| Summa, JD | 1 |
| Tillement, JP | 1 |
| Albengres, E | 1 |
| Choisy, H | 1 |
| Millart, H | 1 |
| Schettler, G | 2 |
| Paredero Del Bosque Martin, V | 1 |
| Nestel, PJ | 4 |
| Hunt, D | 1 |
| Wahlqvist, ML | 1 |
| Yeshurun, D | 4 |
| Gotto, AM | 5 |
| Shepherd, J | 3 |
| Lozada, A | 1 |
| Dujovne, CA | 2 |
| Föger, B | 1 |
| Tröbinger, G | 1 |
| Ritsch, A | 1 |
| Lechleitner, M | 1 |
| Hopferwieser, T | 1 |
| Menzel, HJ | 1 |
| Utermann, G | 1 |
| Pfeiffer, KP | 1 |
| Patsch, JR | 3 |
| Hattori, T | 1 |
| Nagamatsu, T | 1 |
| Ito, M | 1 |
| Suzuki, Y | 1 |
| Schiel, R | 1 |
| Bambauer, R | 1 |
| Müller, UA | 1 |
| Farmer, JA | 1 |
| Davignon, J | 8 |
| Balkau, B | 1 |
| Charles, MA | 1 |
| Eschwège, E | 1 |
| Knopp, RH | 1 |
| Linton, MF | 1 |
| Fazio, S | 1 |
| Tada, N | 1 |
| Bremer, J | 1 |
| Idzior-Waluś, B | 1 |
| Klungel, OH | 1 |
| Heckbert, SR | 1 |
| de Boer, A | 1 |
| Leufkens, HG | 1 |
| Sullivan, SD | 1 |
| Fishman, PA | 1 |
| Veenstra, DL | 1 |
| Psaty, BM | 1 |
| Haase, W | 4 |
| Kaffarnik, H | 6 |
| Whitaker, KB | 1 |
| Costa, D | 1 |
| Moss, DW | 1 |
| Schade, RW | 1 |
| Demacker, PN | 1 |
| van T Laar, A | 1 |
| Thompson, GR | 1 |
| Lowenthal, R | 1 |
| Myant, NB | 3 |
| Glusa, E | 1 |
| Ryan, JR | 2 |
| Pierides, AM | 1 |
| Alvarez-Ude, F | 1 |
| Kerr, DN | 1 |
| Dosa, S | 1 |
| Mallick, NP | 1 |
| Slotki, IN | 1 |
| Bateson, MC | 4 |
| Teräväinen, H | 1 |
| Mäkitie, J | 1 |
| Belsiche, J | 1 |
| Le Carrier, M | 1 |
| Krainik, F | 1 |
| Cattan, D | 1 |
| Taylor, KG | 1 |
| Holdsworth, G | 1 |
| Galton, DJ | 1 |
| Tuomilehto, J | 3 |
| Schwandt, P | 6 |
| Klinge, O | 1 |
| Immich, H | 1 |
| Downie, CC | 1 |
| Carlson, LA | 6 |
| Elkeles, RS | 1 |
| Ilyas, M | 1 |
| Peracha, MA | 1 |
| Ali, N | 1 |
| Husnain Sherazi, SM | 1 |
| Mahmood, N | 1 |
| Adam, O | 1 |
| Wolfram, G | 6 |
| Zöllner, N | 2 |
| Schwartzkopff, W | 4 |
| Danielsson, A | 1 |
| Ek, B | 1 |
| Nyhlin, H | 1 |
| Steen, L | 1 |
| Angelin, B | 1 |
| Einarsson, K | 3 |
| Leijd, B | 1 |
| Cagli, V | 1 |
| Lillo, V | 1 |
| Martin, PH | 1 |
| Oudot, J | 1 |
| Dyerberg, J | 1 |
| Brown, HB | 1 |
| Lewis, LA | 1 |
| Page, IH | 1 |
| Witte, EC | 1 |
| Hazzard, ER | 1 |
| Bierman, EL | 3 |
| Rider, AK | 1 |
| Cabana, VG | 1 |
| Warnick, GR | 1 |
| Stein, EA | 1 |
| Heimann, KW | 1 |
| Wessels, G | 2 |
| Korte, R | 1 |
| Lowe, H | 1 |
| Jung, W | 1 |
| Kremer, GJ | 1 |
| Müller, D | 1 |
| Jain, AK | 1 |
| McMahon, FG | 1 |
| Ritland, S | 2 |
| Fausa, O | 1 |
| Gjone, E | 2 |
| Blomhoff, JP | 1 |
| Skrede, S | 1 |
| Lanner, A | 2 |
| Rouffy, J | 3 |
| Stone, MC | 1 |
| Thorp, JM | 2 |
| Wain, JS | 1 |
| Steinberg, D | 1 |
| Weinstein, DB | 1 |
| Carew, TE | 1 |
| De Gennes, JL | 3 |
| Turpin, G | 4 |
| Lambrozo, J | 1 |
| Truffert, J | 3 |
| Orö, L | 2 |
| Azarnoff, DL | 2 |
| Huffman, DH | 1 |
| Pentikäinen, P | 1 |
| Hurwitz, A | 1 |
| Shoeman, DW | 1 |
| Hoffmann, H | 1 |
| Kästner, W | 1 |
| Weisweiler, P | 3 |
| Neureuther, G | 1 |
| Wilkening, J | 1 |
| Mathew, NT | 1 |
| Meyer, JS | 1 |
| Achari, AN | 1 |
| Dodson, RF | 1 |
| Harcos, P | 1 |
| Márkus, A | 1 |
| Péter, A | 1 |
| Pucsok, J | 1 |
| Ditzel, J | 1 |
| Bang, HO | 1 |
| Dreux, C | 1 |
| Goussault, Y | 1 |
| Dakkak, R | 1 |
| Renson, FJ | 1 |
| Reman, FC | 1 |
| Van der Voort, H | 1 |
| Van Gent, CM | 1 |
| Reinders, J | 1 |
| Gaertner, U | 1 |
| Johannes, KJ | 1 |
| Loizzi, P | 1 |
| Terlizzi, N | 1 |
| Fisher, WR | 2 |
| Truitt, DH | 1 |
| Patsch, W | 1 |
| Sailer, S | 4 |
| Braunsteiner, H | 2 |
| Krivoruchenko, IV | 1 |
| Nikul'cheva, NG | 2 |
| Mok, HY | 2 |
| Glueck, CJ | 1 |
| Fallat, RW | 1 |
| Mellies, MJ | 1 |
| Steiner, PM | 1 |
| Micheli, H | 3 |
| Kim, J | 1 |
| Goldfischer, S | 1 |
| Biempica, L | 1 |
| Howard, AN | 2 |
| Ghosh, P | 1 |
| Bielmann, P | 1 |
| Brun, D | 1 |
| Moorjani, S | 1 |
| Gagnon, MA | 1 |
| Tétreault, L | 1 |
| Lupien, PJ | 1 |
| Olsson, G | 1 |
| Ballantyne, D | 3 |
| Gianoulakis, C | 3 |
| Passerini, L | 1 |
| Lis, M | 2 |
| Chrétien, M | 3 |
| Koschinsky, T | 3 |
| Gries, FA | 4 |
| Hansen, W | 1 |
| Nijssen, J | 1 |
| Beckmann, R | 1 |
| Zschiedrich, M | 2 |
| Vogelberg, KH | 6 |
| Althoff, B | 1 |
| Heggen, EM | 1 |
| Thesseling, W | 1 |
| Hellström, K | 2 |
| Bruns, W | 2 |
| Leonhardt, ET | 1 |
| Ballantyne, FC | 2 |
| Stromberg, P | 1 |
| Third, JL | 1 |
| Bedford, DK | 1 |
| Berman, M | 1 |
| Hall, M | 1 |
| Levy, RI | 8 |
| Eisenberg, S | 2 |
| Bilheimer, DW | 1 |
| Phair, RD | 1 |
| Goebel, RH | 1 |
| Mordasini, R | 4 |
| Herrmann, W | 1 |
| Reuter, W | 5 |
| Jackson, RL | 1 |
| Sznajderman, M | 2 |
| Müller, A | 1 |
| Klose, G | 2 |
| Middelhoff, G | 2 |
| Augustin, J | 4 |
| Greten, H | 3 |
| Mertz, DP | 2 |
| Suermann, J | 1 |
| De Rosa, L | 1 |
| Giangrandi, E | 1 |
| Murante, N | 1 |
| Scaroina, F | 1 |
| Cayen, MN | 2 |
| Dvornik, D | 2 |
| Gomarasca, P | 1 |
| D'Atri, G | 1 |
| Cerutti, S | 1 |
| Tronconi, G | 1 |
| Scolastico, C | 1 |
| Kobayakawa, T | 1 |
| Osuga, K | 1 |
| Yasuda, H | 1 |
| Sherrard, DJ | 3 |
| Brunzell, JD | 3 |
| Wallentin, L | 1 |
| Colman, RW | 4 |
| Arntz, HR | 2 |
| Leonhardt, H | 1 |
| Dreykluft, HR | 1 |
| Gustafson, A | 5 |
| Müller, R | 1 |
| Buberl, W | 1 |
| Schubotz, R | 1 |
| Hausmann, L | 1 |
| Mühlfellner, G | 1 |
| Mühlfellner, O | 1 |
| Falko, JM | 1 |
| Witztum, JL | 1 |
| Schonfeld, G | 1 |
| Weidman, SW | 1 |
| Kolar, JB | 1 |
| Meinders, AE | 1 |
| Schlesinger, M | 1 |
| Jacotot, B | 1 |
| Beaumont, V | 2 |
| Buxtorf, JC | 1 |
| Lehtonen, A | 2 |
| Viikari, J | 2 |
| Nestruck, AC | 3 |
| Bucalossi, A | 1 |
| Buzzelli, G | 1 |
| D'Alessandro, A | 1 |
| Goldberg, AP | 2 |
| Applebaum-Bowden, DM | 1 |
| Haas, LB | 2 |
| Huttunen, JK | 2 |
| Ehnholm, C | 1 |
| Nikkila, EA | 3 |
| Hart, A | 1 |
| Carvalho, AC | 2 |
| Lees, RS | 5 |
| Vaillancourt, RA | 1 |
| Krut, LH | 1 |
| Seftel, HC | 1 |
| Joffe, BI | 1 |
| Gniwotta, E | 1 |
| Herter, B | 1 |
| Ljunghall, S | 1 |
| Schacht, E | 1 |
| Fischer, M | 1 |
| Falkensammer, C | 1 |
| Yü, TF | 1 |
| Dorph, DJ | 1 |
| Smith, H | 1 |
| Heel, RC | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Koskinen, P | 1 |
| Inkovaara, J | 1 |
| Ala-Kaila, K | 1 |
| Salo, M | 1 |
| Nikkari, T | 1 |
| Zannino, L | 1 |
| Salvadori, G | 1 |
| Gatti, A | 1 |
| Carletta, C | 1 |
| Scott, HW | 1 |
| Lundqvist, G | 1 |
| Kissebah, AH | 2 |
| Robinson, WT | 1 |
| Dubuc, J | 1 |
| Vaisrub, S | 1 |
| Mamchenko, GF | 1 |
| Arnold, A | 1 |
| McAuliff, JP | 1 |
| Powers, LG | 1 |
| Phillips, DK | 1 |
| Beyler, AL | 1 |
| Harker, LA | 1 |
| Hazzard, W | 1 |
| Giuliani, A | 1 |
| Trezzini, C | 1 |
| Urbinati, G | 1 |
| Conti, R | 1 |
| Dimroth, H | 1 |
| Hartmann, G | 2 |
| Noseda, G | 1 |
| Stähelin, HB | 5 |
| Maderspach, A | 1 |
| Orbán, E | 1 |
| Borsy, J | 1 |
| Fischer, J | 1 |
| Viikinkoski, P | 1 |
| Priego, JG | 3 |
| Maroto, ML | 3 |
| Piña, M | 3 |
| Catalán, RE | 3 |
| Stein, Y | 2 |
| Jonescu, V | 1 |
| Kritchevsky, D | 1 |
| Colombo, L | 1 |
| Monarca, A | 1 |
| Goldberg, D | 1 |
| Zanetta, R | 1 |
| Nicrosini, F | 1 |
| Pasotti, C | 1 |
| Pistautz, H | 1 |
| Asano, M | 1 |
| di Giulio, S | 1 |
| Boulu, R | 1 |
| Drüeke, T | 1 |
| Nicolaĭ, A | 1 |
| Zingraff, J | 1 |
| Crosnier, J | 1 |
| Roncari, DA | 1 |
| Pfeiffer, M | 1 |
| Tilsner, V | 1 |
| Fodor, GP | 1 |
| Fleischmajer, R | 1 |
| Muller, DP | 1 |
| Pavlou, C | 1 |
| Whitelaw, AG | 1 |
| McLintock, D | 1 |
| Wollenweber, J | 1 |
| Magnusson, O | 2 |
| Andersson, I | 1 |
| Nordlund, L | 1 |
| Ross, PE | 2 |
| Murison, J | 1 |
| Bouchier, IA | 3 |
| Maclean, D | 2 |
| Evans, JR | 1 |
| Válek, J | 1 |
| Grafnetter, D | 1 |
| Englis, M | 1 |
| Matl, I | 1 |
| Simonelli, C | 1 |
| Eaton, RP | 1 |
| Smith, FR | 1 |
| Noble, RP | 3 |
| Goodman, DS | 3 |
| Morrison, BA | 1 |
| Dryburgh, FJ | 1 |
| Epenetos, AA | 1 |
| Wahl, P | 1 |
| Hasslacher, C | 1 |
| Kalachi, I | 1 |
| Aygen, M | 1 |
| Pick, AI | 1 |
| Rosenfeld, I | 1 |
| Atsmon, A | 1 |
| Vilageliu, J | 1 |
| Zapatero, MD | 1 |
| Bruseghini, L | 1 |
| Klemens, UH | 2 |
| Vollmar, LJ | 1 |
| Cassi, E | 1 |
| Massarotti, G | 1 |
| Bernieri, A | 1 |
| Cova, L | 1 |
| Colombo, A | 1 |
| Beretta, R | 1 |
| Pagani, C | 1 |
| Kuppurajan, K | 1 |
| Rajagopalan, SS | 1 |
| Rao, TK | 1 |
| Sitaraman, R | 1 |
| Sangiorgi, M | 1 |
| Martinelli, M | 1 |
| Voss, K | 1 |
| Kemmer, C | 2 |
| Patel, RB | 1 |
| Gandhi, TP | 1 |
| Shah, GF | 1 |
| Patel, AA | 1 |
| Patel, VC | 1 |
| Palmer, RH | 1 |
| Ciświcka-Sznajderman, M | 2 |
| Hansen, PF | 3 |
| West, RJ | 1 |
| Fosbrooke, AS | 4 |
| Lloyd, JK | 4 |
| Knipping, W | 1 |
| Ahrens, EH | 3 |
| Rees, ED | 1 |
| Hamilton, RD | 2 |
| Kanner, IF | 1 |
| Wasson, S | 1 |
| Hearn, T | 1 |
| Salonen, J | 1 |
| Kuuisto, P | 1 |
| Virtamo, J | 1 |
| Eisalo, A | 1 |
| Michaelis, D | 1 |
| Müller, H | 1 |
| Busch, G | 1 |
| Loew, H | 1 |
| Rodney, G | 1 |
| Uhlendorf, P | 1 |
| Maxwell, RE | 1 |
| Kijima, Y | 2 |
| Sasaoka, T | 2 |
| Kanayama, M | 2 |
| Kubota, S | 2 |
| Kurokawa, K | 1 |
| Delbarre, F | 1 |
| Rondier, J | 1 |
| de Géry, A | 1 |
| Zimmermann, R | 1 |
| Hoffrichter, A | 1 |
| Walter, E | 1 |
| Ehlers, W | 1 |
| Andrassy, K | 1 |
| Schlierf, G | 5 |
| Weber, E | 1 |
| Barth, P | 1 |
| Laible, V | 1 |
| Zipperle, G | 1 |
| Cucinotta, D | 1 |
| Palummeri, E | 1 |
| Ceccato, S | 1 |
| Passeri, M | 1 |
| Overzier, C | 1 |
| Zakharov, VN | 1 |
| Marek, H | 1 |
| Kuklinski, B | 1 |
| Hunger, R | 1 |
| Albertini, F | 1 |
| Boberg, M | 1 |
| Gross, R | 1 |
| Grundy, S | 1 |
| Brown, V | 1 |
| Graham, L | 1 |
| Mulcahy, R | 1 |
| Hickey, N | 1 |
| Kudchodkar, BJ | 4 |
| Sodhi, HS | 4 |
| Horlick, DL | 1 |
| Mason, DT | 2 |
| Deriagina, GP | 1 |
| Walldius, G | 1 |
| Lenhard, P | 1 |
| Högberg, T | 1 |
| Bondesson, G | 1 |
| Stjernström, NE | 1 |
| Singer, P | 1 |
| Gnauck, G | 1 |
| Honigmann, G | 1 |
| Thoelke, H | 1 |
| Schliack, V | 1 |
| Läuter, J | 1 |
| Hull, L | 1 |
| Frantz, ID | 1 |
| Jones, RJ | 2 |
| Malhotra, SC | 2 |
| Ahuja, MM | 2 |
| Sundaram, KR | 1 |
| Huttunen, J | 1 |
| Lees, AM | 1 |
| Basta, LL | 1 |
| Williams, C | 1 |
| Kioschos, JM | 1 |
| Spector, AA | 2 |
| Hayashi, E | 1 |
| Yamada, J | 1 |
| Kunitomo, M | 1 |
| Terada, M | 1 |
| Tomita, T | 1 |
| Panoff, A | 1 |
| Milanoff, G | 1 |
| Henkes, HE | 1 |
| Houtsmuller, AJ | 2 |
| Bos, PJ | 1 |
| Crone, RA | 1 |
| Kuwano, E | 1 |
| Sankrappa, SK | 1 |
| Rumpf, KW | 1 |
| Quellhrost, E | 1 |
| Scheler, F | 1 |
| Buchmann, P | 1 |
| Strub, P | 1 |
| Göschke, H | 1 |
| Thiel, G | 1 |
| Koller, F | 1 |
| Fromantin, M | 1 |
| Garraud, R | 1 |
| Auriche, M | 1 |
| Jaillard, J | 3 |
| Drost, H | 1 |
| Grüneklee, D | 1 |
| Korthaus, G | 1 |
| Watermeyer, GS | 1 |
| Mann, JI | 1 |
| Truswell, AS | 1 |
| Levy, I | 1 |
| Schäfer, B | 1 |
| Kluthe, R | 1 |
| Mann, S | 1 |
| Maisenbacher, HJ | 1 |
| Caruzzo, C | 2 |
| Torreggiani, D | 1 |
| Fumagalli, R | 3 |
| Smith, LK | 1 |
| Luepker, RV | 1 |
| Rothchild, SS | 1 |
| Gillis, A | 1 |
| Kochman, L | 1 |
| Warbasse, JR | 1 |
| Parsons, WB | 1 |
| West, R | 1 |
| Wolff, OH | 4 |
| Horlick, L | 3 |
| Nazir, DJ | 1 |
| Haut, H | 1 |
| Kubasta, M | 1 |
| Vaverková, H | 1 |
| Tiengo, A | 2 |
| Muggeo, M | 2 |
| Assan, R | 1 |
| Fedele, D | 2 |
| Crepaldi, G | 4 |
| Rowe, WS | 1 |
| Tierney, E | 1 |
| Steele, P | 1 |
| Battock, D | 1 |
| Genton, E | 1 |
| Schapel, GJ | 2 |
| Edwards, KD | 3 |
| Rossini, L | 1 |
| Lenzi, S | 1 |
| Norum, KR | 1 |
| Margolis, S | 3 |
| Sirtori, C | 2 |
| Drouin, P | 1 |
| Gay, G | 1 |
| Pointel, JP | 1 |
| Sauvanet, JP | 1 |
| Debry, G | 1 |
| Kudchodkar, B | 1 |
| Creff, AF | 1 |
| Rottiers, R | 1 |
| van Egmond, J | 1 |
| Studlar, M | 2 |
| Pichler, O | 2 |
| Kindler, K | 1 |
| Ceruso, D | 1 |
| Frisina, N | 1 |
| Nicita-Mauro, V | 1 |
| Andreani, F | 1 |
| Andrisano, R | 1 |
| Andreani, A | 1 |
| Beckmann, VR | 1 |
| Keller, C | 1 |
| Kilani, S | 1 |
| Faergeman, AO | 1 |
| Wilke, H | 2 |
| Frahm, H | 2 |
| Pauchant, M | 1 |
| Bourbillon, JP | 1 |
| Laake, K | 1 |
| Borchgrevink, C | 1 |
| Haacke, H | 1 |
| Kolenda, KD | 1 |
| Husek, P | 1 |
| Sankarappa, SK | 1 |
| Rahlfs, VW | 1 |
| Itakura, H | 1 |
| Dunnigan, MG | 2 |
| Steiner, G | 1 |
| Russell, JC | 1 |
| Koeslag, DG | 1 |
| Amy, RM | 1 |
| Dolphin, PJ | 1 |
| Mazzella, G | 1 |
| Bazzoli, F | 1 |
| Villanova, N | 1 |
| Simoni, P | 1 |
| Festi, D | 1 |
| Roda, A | 1 |
| Aldini, R | 1 |
| Roda, E | 1 |
| Heshmati, HM | 1 |
| Touitou, Y | 1 |
| Varsaux, J | 1 |
| Roger, M | 1 |
| Nahoul, K | 1 |
| Bogdan, A | 1 |
| Auzeby, A | 1 |
| McCormick, SP | 1 |
| Fellowes, AP | 1 |
| Brennan, SO | 1 |
| George, PM | 1 |
| Naukkarinen, V | 1 |
| Strandberg, T | 1 |
| Vanhanen, H | 1 |
| Raheja, KL | 1 |
| Linscheer, WG | 1 |
| Cho, C | 1 |
| Bickley, L | 1 |
| Dadej, R | 1 |
| Nakagawa, M | 1 |
| Shimokawa, T | 1 |
| Kojima, S | 1 |
| Zhang, BZ | 1 |
| Kancelarczyk, WL | 1 |
| Petit, D | 1 |
| Bonnefis, MT | 1 |
| Rey, C | 1 |
| Infante, R | 1 |
| Malloy, MJ | 1 |
| Naito, HK | 1 |
| Lam, HC | 1 |
| Li, SH | 1 |
| Wang, JT | 1 |
| Tang, KT | 1 |
| Ho, LT | 1 |
| Kasiske, BL | 2 |
| O'Donnell, MP | 2 |
| Garvis, WJ | 1 |
| Keane, WF | 2 |
| Murata, Y | 1 |
| Tani, M | 1 |
| Amano, M | 1 |
| Cleary, MP | 1 |
| Morishita, S | 1 |
| Saito, T | 1 |
| Mishima, Y | 1 |
| Mizutani, A | 1 |
| Hirai, Y | 1 |
| Koyama, S | 1 |
| Kawakami, M | 1 |
| Tikkanen, MJ | 1 |
| Perry, RS | 1 |
| Malinow, MR | 1 |
| Jones, PH | 1 |
| Scott, LW | 1 |
| Packard, CJ | 2 |
| Mai, K | 1 |
| Stuyt, PM | 1 |
| Oster, P | 2 |
| Janus, ED | 1 |
| Grant, S | 1 |
| Lintott, CJ | 1 |
| Wardell, MR | 1 |
| Fenwick, GR | 1 |
| Hanley, AB | 1 |
| Gutman, R | 1 |
| Basílico, MZ | 1 |
| Chicco, A | 1 |
| de Rodi, MA | 1 |
| Nusimovich, B | 1 |
| Lombardo, YB | 1 |
| Pande, SV | 1 |
| Mas, JL | 1 |
| Bousser, MG | 1 |
| Lacombe, C | 1 |
| Agar, N | 1 |
| Parker, F | 2 |
| Krishnamurthy, A | 1 |
| Thapar, GS | 1 |
| Shridhar, DR | 1 |
| de Meglio, P | 1 |
| Ravenna, F | 1 |
| Manzardo, S | 1 |
| Gentili, P | 1 |
| Riva, M | 1 |
| Bridgman, JF | 1 |
| Rosen, SM | 1 |
| McGarvey, JF | 1 |
| Mărgineanu, O | 1 |
| Miu, N | 1 |
| Szantay, V | 1 |
| Acalovschi, R | 1 |
| Locher, JT | 2 |
| Maier, R | 2 |
| Fredrickson, DS | 2 |
| Segall, MM | 2 |
| Fritz, T | 1 |
| Jolly, H | 1 |
| Segal, P | 1 |
| Roheim, PS | 1 |
| Eder, HA | 1 |
| Penttilä, IM | 1 |
| Lampainen, E | 1 |
| Wilson, DE | 2 |
| Haviar, V | 2 |
| Riecanský, L | 1 |
| Kusá, O | 2 |
| Luknárová, O | 2 |
| Eaton, BP | 1 |
| Nye, WH | 1 |
| Rufli, T | 1 |
| Stähelin, H | 1 |
| Wolfe, BM | 1 |
| Brewster, HP | 1 |
| von Löwis, P | 1 |
| Kwiterovich, PO | 1 |
| Salvati, A | 1 |
| Rifking, BM | 1 |
| Cochrane, MA | 1 |
| Kelly, A | 1 |
| Scott, JW | 1 |
| Morganroth, J | 1 |
| Rifkind, BM | 2 |
| Blaton, V | 1 |
| Declercq, B | 1 |
| Vercruysse, J | 1 |
| Vandamme, D | 1 |
| Peeters, H | 1 |
| Mortelmans, J | 1 |
| Grossberg, SE | 1 |
| Frerman, FE | 1 |
| Lengle, EE | 1 |
| Roch, LA | 1 |
| Hron, WT | 1 |
| Dixon, M | 1 |
| Appelbaum, JJ | 1 |
| Amundsen, MA | 1 |
| Perkin, DK | 1 |
| Fellin, R | 2 |
| Briani, G | 2 |
| Baggio, G | 1 |
| Baiocchi, MR | 1 |
| Raetzer, H | 1 |
| Toscano, S | 1 |
| Polano, MK | 1 |
| Albrink, MJ | 1 |
| Bybee, DE | 1 |
| Neuman, J | 1 |
| de Neuman, MP | 1 |
| Talmasky, S | 1 |
| Pesce, R | 1 |
| Valero, E | 1 |
| Martiarena, JL | 1 |
| Emmrich, R | 1 |
| Frisk-Holmberg, M | 1 |
| Kucerová, L | 1 |
| Voslárová, Z | 1 |
| Papezová, R | 1 |
| Knüchel, F | 2 |
| Neale, FC | 1 |
| Suzuki, K | 1 |
| Aono, S | 1 |
| Nakatani, H | 1 |
| Carmena, R | 1 |
| Sanchis, J | 1 |
| Leutenegger, M | 1 |
| Neugebauer, A | 1 |
| Trenckmann, H | 1 |
| Duck, HJ | 1 |
| Fleischmann, HJ | 1 |
| Schauer, J | 1 |
| Rjasanowski, I | 1 |
| Wulfert, P | 1 |
| Michael, R | 1 |
| Knospe, S | 1 |
| Hildmann, W | 1 |
| Schultz, A | 1 |
| Krüskemper, HL | 1 |
| Labrousse, B | 1 |
| Anet, P | 2 |
| Brouns, H | 2 |
| van den Abelle, KG | 1 |
| Delescluse, A | 2 |
| Bar-On, H | 1 |
| Kekki, M | 1 |
| Klimov, AN | 1 |
| Sandhofer, F | 1 |
| Zelis, R | 1 |
| Amsterdam, EA | 1 |
| Spann, JF | 1 |
| Michajlik, A | 1 |
| Berkowitz, D | 3 |
| Heady, JA | 1 |
| Krikler, DM | 1 |
| Baiotti, G | 1 |
| Sachs, BA | 1 |
| Bardfeld, PA | 1 |
| Bodian, JE | 1 |
| Sugarman, LA | 1 |
| Hellman, L | 1 |
| Paoletti, R | 2 |
| Buchwald, H | 1 |
| Moore, RB | 1 |
| Varco, RL | 1 |
| Fenster, R | 1 |
| Bagdade, JD | 2 |
| Nakano, Y | 1 |
| Fukui, I | 1 |
| Niiho, S | 1 |
| Kuki, H | 1 |
| Takahata, J | 1 |
| Fourrier, A | 1 |
| Mouton, Y | 1 |
| Howe, R | 1 |
| Strasek, J | 1 |
| Jaross, W | 1 |
| Trübsbach, A | 1 |
| Chait, A | 1 |
| Cloarec, M | 2 |
| Jepson, EM | 1 |
| Oye, I | 3 |
| Hammerl, H | 1 |
| Nebosis, G | 1 |
| Fabre, J | 1 |
| Denizot, M | 1 |
| Wildi, E | 1 |
| Berthoud, S | 1 |
| Sirtori, R | 1 |
| Brownstein, S | 1 |
| Font, RL | 1 |
| Alper, MG | 1 |
| Bavina, MV | 1 |
| Perova, NV | 1 |
| Lobova, NM | 1 |
| Koropova, GI | 1 |
| Malcolm, J | 2 |
| Lockwood, P | 1 |
| Hunt, P | 1 |
| Thomas, B | 1 |
| Heilman, WP | 1 |
| Irsigler, K | 3 |
| Flegel, U | 2 |
| Kühn, P | 1 |
| Schubert, H | 1 |
| Iván, E | 1 |
| Biro, L | 1 |
| Székely, L | 1 |
| Bobnis, W | 1 |
| Szmatloch, E | 1 |
| Wesolowska, T | 1 |
| Wójcicki, J | 1 |
| Zieliński, T | 1 |
| Dell, RB | 1 |
| Spreafico, PL | 1 |
| Frandoli, G | 1 |
| Turazza, G | 1 |
| Scott, PJ | 1 |
| Ochs, H | 1 |
| Weber, K | 1 |
| Braun-Falco, O | 1 |
| Kallner, M | 1 |
| Teoh, PC | 1 |
| Kovać, T | 1 |
| Vitić, B | 1 |
| Cuculanu, MP | 1 |
| Vasile, VV | 1 |
| Popescu, TA | 1 |
| Opincaru, A | 2 |
| Crîsnic, I | 1 |
| Tapalagå, D | 1 |
| Mirouze, J | 1 |
| Orsetti, A | 1 |
| Cartry, E | 1 |
| Huth, K | 1 |
| Blumenthal, J | 1 |
| Schmahl, FW | 1 |
| Stanulović, D | 1 |
| Stojsić, D | 1 |
| Warembourg, H | 2 |
| Hărăguş, S | 1 |
| Uza, G | 1 |
| Cucuianu, M | 1 |
| Fenderson, RW | 1 |
| Sekowski, I | 2 |
| Mohan, C | 1 |
| Deutsch, S | 1 |
| Benjamin, F | 1 |
| Pertsemlidis, D | 1 |
| Panveliwalla, D | 1 |
| Slack, J | 1 |
| Heilman, KM | 1 |
| Adams, PW | 1 |
| Harrigan, P | 1 |
| Wynn, V | 1 |
| Pagnan, A | 1 |
| Tonolli, E | 1 |
| Jonker, JJ | 1 |
| Veen, MR | 1 |
| Schopman, W | 1 |
| den Ottolander, GJ | 1 |
| Sachlová, M | 1 |
| Hofman, J | 1 |
| Zwetschke, O | 1 |
| Zsernaviezky, J | 1 |
| von Torklus, D | 1 |
| Plamieniak, L | 1 |
| Miyoshi, F | 1 |
| Kuroda, H | 1 |
| Hiraoka, K | 1 |
| Fukami, H | 1 |
| Onishi, K | 1 |
| Seifert, A | 2 |
| Short, JM | 1 |
| Müller, G | 1 |
| Gomes, MM | 1 |
| Bernatz, PE | 1 |
| Kottke, BA | 1 |
| Juergens, JL | 1 |
| Titus, JL | 1 |
| Barter, PJ | 1 |
| Carroll, KF | 1 |
| Kahlke, W | 1 |
| Schurr, PE | 1 |
| Schultz, JR | 1 |
| Parkinson, TM | 1 |
| Amidi, M | 1 |
| Likoff, W | 1 |
| Salen, G | 1 |
| Schreibman, PH | 1 |
| Riecanský, I | 1 |
| LaRosa, JC | 1 |
| Hoffer, A | 1 |
| Krasno, LR | 1 |
| Kidera, GJ | 1 |
| Ylikahri, R | 1 |
| Kähönen, M | 1 |
| Van den Abbeele, KG | 1 |
| Cagánová, A | 2 |
| Cagán, S | 2 |
| Weiss, P | 1 |
| Ruhrmann, H | 1 |
| Fasoli, A | 1 |
| Porte, D | 1 |
| Pichler, E | 1 |
| Zweymüller, E | 1 |
| Aubry, F | 2 |
| Noël, C | 2 |
| Lapierre, Y | 1 |
| Lafortune, M | 1 |
| Szybiński, Z | 1 |
| Lankosz, J | 1 |
| Kieta-Fyda, A | 1 |
| Bobrowski, A | 1 |
| Biczowa, N | 1 |
| Mareczek, S | 1 |
| Ciammaichella, A | 1 |
| Torcia, L | 1 |
| Takayasu, K | 1 |
| Tada, T | 1 |
| Okada, F | 1 |
| Yoshikawa, I | 1 |
| Avogaro, P | 1 |
| Capri, C | 1 |
| Cazzolato, G | 1 |
| Nakano, M | 1 |
| Nakamura, Y | 1 |
| Bechar, M | 1 |
| Kott, E | 1 |
| Bornstein, B | 1 |
| Holtzman, CM | 1 |
| Meilman, E | 1 |
| Pometta, D | 1 |
| Bergqvist, N | 1 |
| Casdorph, HR | 1 |
| Nordoy, A | 2 |
| Kaunitz, H | 1 |
| Weder, CH | 1 |
| Storey, GO | 1 |
| Lapierre, YL | 1 |
| Dabels, J | 1 |
| Wagner, A | 1 |
| Maha, GE | 1 |
| Sigroth, K | 1 |
| Rodset, JM | 1 |
| Duncan, GG | 1 |
| Elliott, FA | 1 |
| Duncan, TG | 1 |
| Schatanoff, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000482] | Phase 3 | 0 participants | Interventional | 1965-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
68 reviews available for clofibrate and Hyperlipemia
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligand | 2000 |
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
Effects of hypolipidemic drugs on bile acid metabolism in man.
Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Hum | 1981 |
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperl | 1984 |
High-density lipoprotein metabolism.
Topics: Animals; Apolipoproteins; Chemical Phenomena; Chemistry; Cholesterol; Chylomicrons; Clofibrate; Diet | 1980 |
Therapy of hyperlipidemic states.
Topics: Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Colestipol; Dietary Fats; Drug Therapy, Comb | 1982 |
Hyperlipidemia: perspectives in diagnosis and treatment.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Fat-Re | 1995 |
Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety.
Topics: Clinical Trials as Topic; Clofibrate; Drug Therapy, Combination; Humans; Hyperlipidemias; Lovastatin | 1995 |
Drug interactions with fibric acids.
Topics: Anticoagulants; Bezafibrate; Clofibrate; Clofibric Acid; Contraceptives, Oral; Coronary Disease; Dru | 1994 |
Choosing the right lipid-regulating agent. A guide to selection.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrat | 1996 |
Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects.
Topics: Animals; Clofibrate; Drug Evaluation; Drug Evaluation, Preclinical; Drugs, Investigational; Humans; | 1998 |
Drug treatment of lipid disorders.
Topics: Anion Exchange Resins; Cardiovascular Diseases; Clofibrate; Female; Humans; Hydroxymethylglutaryl-Co | 1999 |
Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk.
Topics: Angiography; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; | 2000 |
[Overviews of fibrate].
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL | 2001 |
The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects.
Topics: Animals; Apolipoprotein C-III; Apolipoproteins C; Carnitine O-Palmitoyltransferase; Chylomicrons; Cl | 2001 |
[Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome].
Topics: Cardiovascular Diseases; Clofibrate; Fenofibrate; Hemostasis; Humans; Hyperinsulinism; Hyperlipidemi | 2001 |
The common hyperlipoproteinemias: an understanding of disease mechanisms and their control.
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Ethanol; Humans; Hypercholesterolemia; Hyperlipidemias; | 1976 |
[Familial hyperlipoproteinemia type III].
Topics: Age Factors; Cholesterol; Chylomicrons; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipo | 1976 |
Classifications of the hyperlipidemias.
Topics: Apolipoproteins; Cholesterol; Cholesterol, Dietary; Clofibrate; Dietary Fats; Electrophoresis; Femal | 1977 |
Bile acid metabolism in hyperlipoproteinaemia.
Topics: Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholestyramine Resin; Cholic Acids; Chylomicrons; | 1977 |
Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Topics: Cholesterol; Chylomicrons; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Hypolipidemic Agen | 1975 |
[Lipid-lowering drugs. Therapeutics and adverse effects].
Topics: Arteriosclerosis; Child; Cholelithiasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxi | 1979 |
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; D | 1977 |
Hypolipidaemic aryloxyacetic acids.
Topics: Animals; Chemical Phenomena; Chemistry; Cholesterol; Clofibrate; Drug Evaluation, Preclinical; Glyco | 1977 |
Hyperlipidemia in primary gout.
Topics: Adolescent; Adult; Aged; Aging; Alcohol Drinking; Cholesterol; Clofibrate; Dextrothyroxine; Diabetes | 1978 |
Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.
Topics: Animals; Arteriosclerosis; Clofibrate; Dogs; Humans; Hypercholesterolemia; Hyperlipidemias; Kinetics | 1978 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type | 1979 |
[Pharmacological treatment of primary hyperlipoproteinemia].
Topics: Cholesterol; Clofibrate; Depression, Chemical; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipopr | 1976 |
Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Topics: Alcohol Drinking; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hyper | 1975 |
The management of hyperlipidemia: whether, rather than how.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dietary Fats; Drug Evaluation; | 1976 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
[Current dietetic and pharmacological treatment of hyperlipoproteinemia].
Topics: Anion Exchange Resins; Clofibrate; Dextrothyroxine; Dietary Fats; Humans; Hyperlipidemias; Hypolipid | 1975 |
Mechanism of action of hypolipidemic drugs.
Topics: Acetoacetates; Animals; Brain; Cholesterol; Clofibrate; Colestipol; Ethanol; Humans; Hydroxybutyrate | 1975 |
Effects of various lipid-lowering treatments in diabetics.
Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase I | 1990 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; H | 1988 |
Reducing cardiac deaths with hypolipidemic drugs.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfi | 1987 |
Contemporary recommendations for evaluating and treating hyperlipidemia.
Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lip | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibr | 1986 |
Pharmacological modification of lipoprotein metabolism.
Topics: Animals; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hydroxymethylgl | 1987 |
The genus Allium--Part 3.
Topics: Allium; Animals; Arteriosclerosis; Asthma; Bacteria; Blood Glucose; Blood Protein Electrophoresis; C | 1985 |
A physician's guide to hyperlipidemia.
Topics: Adult; Cholesterol; Chylomicrons; Clofibrate; Diabetes Complications; Diet Therapy; Female; Humans; | 1972 |
Dietary and drug treatment of primary hyperlipoproteinemia.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; | 1972 |
The hyperlipoproteinemias. Detection, diagnosis, and management.
Topics: Adolescent; Adult; Alcohol Drinking; Child; Child, Preschool; Cholestyramine Resin; Clofibrate; Diet | 1973 |
Type IV hyperlipoproteinaemia.
Topics: Child; Cholesterol; Chylomicrons; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohy | 1973 |
Lipid lowering drugs and hyperlipidaemia.
Topics: Biological Transport; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; | 1973 |
Treatment of hyperlipidemia.
Topics: Blood Proteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Costs and Cost Analysis | 1974 |
Dietary and drug treatment of hyperlipidemia in diabetes.
Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes M | 1974 |
The primary hyperlipoproteinemias.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Humans; Hyperc | 1974 |
Does hypolipidemic therapy prevent coronary heart disease?
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Female; Humans; Hyperlip | 1974 |
[Arteriosclerosis--the mutual contribution of the arterial wall cells and serum lipids].
Topics: Age Factors; Aorta; Arteriosclerosis; Cell Membrane; Cholesterol; Chylomicrons; Clofibrate; Diet The | 1972 |
[Types of hyperlipoproteinemia, their relationship to atherosclerosis and treatment].
Topics: Arteriosclerosis; Cholesterol; Chylomicrons; Clofibrate; Densitometry; Dextrothyroxine; Diet Therapy | 1972 |
[Clinical aspects and therapy of primary hyperlipemias].
Topics: Aged; Chylomicrons; Clofibrate; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Lipopro | 1972 |
Antilipaemic drugs and nephrotic hyperlipidaemia.
Topics: Alkenes; Animals; Blood Protein Disorders; Blood Proteins; Butyrates; Clofibrate; Humans; Hyperchole | 1972 |
[Drug prevention of coronary disease].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cholestyramine Resin; Clofibrate; Coronary Diseas | 1972 |
[Hiperlipidemia as a risk factor in coronary artery disease].
Topics: Age Factors; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Diet Therapy; Human | 1973 |
Management of the hyperlipidemic patient.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothy | 1973 |
Therapy of lipid disorders.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet Therapy; Drug | 1973 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; C | 1973 |
Surgical treatment of hyperlipidemia. I. Apologia.
Topics: Arteriosclerosis; Bile; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy | 1974 |
Therapy of the hyperlipoproteinemias.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyper | 1972 |
Individualization of treatment of hyperlipoproteinemic disorders.
Topics: Cholestyramine Resin; Chylomicrons; Clofibrate; Diet, Atherogenic; Drug Interactions; Humans; Hyperl | 1974 |
Hypolipidaemic agents.
Topics: Androgens; Anticholesteremic Agents; Bile Acids and Salts; Chlorobenzenes; Clofibrate; Estrogens; Gl | 1974 |
[The treatment of essential hyperlipidemia with clofibrate].
Topics: Anticholesteremic Agents; Blood Protein Electrophoresis; Cholesterol; Clofibrate; Diabetic Angiopath | 1969 |
Xanthomatosis associated with hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; D | 1970 |
The treatment of hyperlipidemia.
Topics: Bile Acids and Salts; Cholesterol; Chylomicrons; Clofibrate; Dextrothyroxine; Diet Therapy; Fasting; | 1971 |
The effect of diet on lipid metabolism.
Topics: Clofibrate; Diet; Dietary Carbohydrates; Glucose; Glycolysis; Humans; Hyperlipidemias; Liver; Male; | 1971 |
[Therapy of hyperlipidemia].
Topics: Alkenes; Animals; Arteriosclerosis; Cholesterol; Clofibrate; Diet Therapy; Fatty Acids; Humans; Hype | 1971 |
Ileal bypass in treatment of hyperlipidemia: rationale and present status.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Haplorhini; | 1970 |
91 trials available for clofibrate and Hyperlipemia
| Article | Year |
|---|---|
Effect of blood viscosity decrease on exercise ST segment depressions in hyperlipidemia.
Topics: Blood Viscosity; Clinical Trials as Topic; Clofibrate; Dextrans; Exercise Test; Fibrinogen; Humans; | 1980 |
[Therapeutic effects of bezafibrate in hyperlipidemia].
Topics: Adult; Aged; Bezafibrate; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Female; Humans; Hype | 1983 |
Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Clofibrate; | 1984 |
[Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
Topics: Aged; Bezafibrate; Carbohydrate Metabolism; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Di | 1982 |
The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
Topics: Alkaline Phosphatase; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans | 1980 |
A comparison of fenofibrate and clofibrate hypolipidemic effects.
Topics: Anticholesteremic Agents; Cholesterol; Clinical Trials as Topic; Clofibrate; Fenofibrate; Humans; Hy | 1980 |
Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Topics: Adenosine Diphosphate; Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Aci | 1981 |
Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
Topics: Adult; Bezafibrate; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Humans; Hyper | 1981 |
A controlled trial of plasma lipid reduction in peripheral atherosclerosis--an interim report.
Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Fe | 1982 |
High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs.
Topics: Adult; Aged; Aminosalicylic Acid; Apolipoproteins; Cholesterol; Clofibrate; Colestipol; Drug Evaluat | 1980 |
[An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations].
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Doubl | 1980 |
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, | 1995 |
The metabolic spectrum of halofenate.
Topics: Blood Glucose; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Glycolates; Halof | 1975 |
Clofibrate.
Topics: Clinical Trials as Topic; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias; Ne | 1979 |
Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hypercholesterol | 1979 |
Effects of clofibrate in hyperlipidemia: a controlled trial.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipide | 1978 |
[Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)].
Topics: Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hypercho | 1979 |
[Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
Topics: Adult; Aged; Analysis of Variance; Clinical Trials as Topic; Clofibrate; Drug Combinations; Drug Eva | 1975 |
Effects of clofibrate and a fat-modified diet on serum lipids.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Diet; Dietary Fats; Humans; Hyperlip | 1975 |
Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipo | 1975 |
Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Diabetes Mellitus; Drug Synergi | 1975 |
Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids.
Topics: Adolescent; Adult; Anion Exchange Resins; Bile Acids and Salts; Blood Glucose; Cholesterol; Clinical | 1975 |
[Treatment of 100 cases of essential atherogenic hyperlipoproteinemia].
Topics: Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipopro | 1975 |
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Therapy, Combination; Humans; Hyper | 1975 |
One-year trials with halofenate, clofibrate, and placebo.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cho | 1976 |
Clofibrate in type II hyperlipoproteinemia.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Female; Humans; Hypercholesterol | 1976 |
Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
Topics: Clinical Trials as Topic; Clofibrate; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperli | 1976 |
[Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Topics: Adult; Aged; Cholesterol; Chylomicrons; Clofibrate; Drug Combinations; Female; Glycerylphosphorylcho | 1976 |
Gemfibrozil treatment: a comparison with clofibrate.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Li | 1976 |
Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias; Lip | 1977 |
[Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Topics: Adult; Aged; Biguanides; Blood Glucose; Body Weight; Buformin; Cholesterol; Clofibrate; Drug Therapy | 1977 |
Effect of vitamin E on serum cholesterol and triglycerides in hyperlipidemic patients treated with diet and clofibrate.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Fatty Acids, Unsaturated; Female; Hu | 1978 |
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Topics: Cholestanol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Therapy, Comb | 1978 |
[Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Drug Combinations; Female; Humans; Hypercholestero | 1978 |
Effect of polyenyl phosphatidyl choline on clofibrate-induced increase in LDL cholesterol.
Topics: Adult; Aged; Cholesterol; Clofibrate; Double-Blind Method; Drug Combinations; Drug Interactions; Fem | 1979 |
Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
Topics: Adult; Calcium Carbonate; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Li | 1979 |
Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
Topics: Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Female; Glycolates; | 1977 |
[Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemia | 1977 |
Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen.
Topics: Blood Glucose; Blood Sedimentation; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; | 1977 |
Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
Topics: Calcium; Calcium Carbonate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Evaluat | 1977 |
[New drug combination for medical management of hyperlipemia: clinical study].
Topics: Aged; Blood Glucose; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; | 1977 |
Effect of calcium p-chlorphenoxyisobutyrate and calcium carbonate on plasma lipids and lipoproteins of patients with hyperlipoproteinaemia.
Topics: Adult; Alkaline Phosphatase; Calcium Carbonate; Cholesterol; Clinical Trials as Topic; Clofibrate; D | 1977 |
Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.
Topics: Adult; Aged; Chenodeoxycholic Acid; Cholesterol; Clofibrate; Humans; Hyperlipidemias; Liver Function | 1978 |
[Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Topics: Adult; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Male; Middle Aged; Placebos; Trigly | 1978 |
The efficacy of lipid lowering drugs alone and in combination.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Dextrothyroxine; Drug Evalu | 1975 |
Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Topics: Alcohol Drinking; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Humans; Hyper | 1975 |
Treatment of children with familial hypercholesterolaemia.
Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Fem | 1975 |
[Letter: Etofibrate and clofibrate in double blind study].
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Humans; Hyperlipidemias; Statistics as Topic; Tri | 1976 |
The management of hyperlipidemia: whether, rather than how.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dietary Fats; Drug Evaluation; | 1976 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
Topics: Adult; Blood Chemical Analysis; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Fema | 1976 |
A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
Topics: Arteriosclerosis; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias | 1976 |
Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias; Hyp | 1976 |
[Oral anticoagulants and platelet function in hypolipemic therapy using a new clofibrate analog (BM 15.075) (author's transl)].
Topics: Aged; Blood Coagulation; Blood Platelets; Clofibrate; Drug Synergism; Female; Fibrinogen; Humans; Hy | 1977 |
Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
Topics: Analysis of Variance; Cholesterol; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Female; H | 1977 |
Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia.
Topics: Benzamides; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprot | 1977 |
[Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
Topics: Adult; Body Weight; Cholesterol; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyperlipidem | 1977 |
[Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Clofibrate; Drug Combinations; Humans; Hyperlipidemias; | 1976 |
Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
Topics: Adolescent; Adult; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as T | 1975 |
[The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemia | 1975 |
[Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Drug Combinations; Drug Therapy, Combination; Hum | 1975 |
[Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
Topics: Chemical Phenomena; Chemistry; Clinical Trials as Topic; Clofibrate; Humans; Hypercholesterolemia; H | 1975 |
Management of type IV hyperlipoproteinemia. Evaluation of practical clinical approaches.
Topics: Adult; Arteriosclerosis; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Hum | 1976 |
A one year double blind study of the effect of halofenate and clofibrate in patients with hyperlipoproteinemia.
Topics: Clofibrate; Drug Evaluation; Glycolates; Halofenate; Humans; Hyperlipidemias | 1975 |
[Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
Topics: Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; N | 1976 |
[Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
Topics: Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Inositol; Male; Nicotinic Acids; Triglycer | 1976 |
Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholesterol; Clofibrate; Female; Gemfibrozil; Humans; Hyper | 1990 |
Long-term use of probucol in the multifactorial primary prevention of vascular disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cerebrovascular Disorders; Cholesterol, HDL; C | 1986 |
The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Diabetes Complications; Double-Bl | 1987 |
Diurnal lipid and lipoprotein profiles in hypertriglyceridemic patients with bezafibrate and clofibrate.
Topics: Adult; Aged; Bezafibrate; Circadian Rhythm; Clofibrate; Dietary Fats; Double-Blind Method; Female; H | 1986 |
[Proceedings: Effect of alufibrate (Atherolip) on pyruvate and lipoprotein metabolism in patients with hyperlipidemia type IV].
Topics: Acetyl Coenzyme A; Acetyl-CoA Carboxylase; Clinical Trials as Topic; Clofibrate; Fatty Acids; Humans | 1974 |
Treatment of essential hyperlipidaemia.
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; H | 1970 |
Treatment of familial hypercholesterolaemia in children.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Di | 1970 |
The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
Topics: Adult; Cholesterol; Clofibrate; Coronary Disease; Dextrothyroxine; Electrocardiography; Estrogens, C | 1972 |
[Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Ambulatory Care; Anticoagulants; Aspartate | 1973 |
Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Dextrans; Diethylamines; Female; Humans; Hypercholester | 1974 |
Does hypolipidemic therapy prevent coronary heart disease?
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Female; Humans; Hyperlip | 1974 |
A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Topics: Cholesterol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Glycolates; Halofenate; Humans; Hyp | 1973 |
Plasma endogenous triglyceride transport in hypertriglyceridaemia and effect of a hypolipidaemic drug (SU-13437).
Topics: Adult; Biological Transport; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias; | 1972 |
Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Diet Therapy; Evaluation Studies as Topic; | 1972 |
A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Coronary Disease; Europe; Humans; Hyperlipidemias; Inte | 1973 |
[Etamysylate in the treatment of essential hyperlipemia].
Topics: Adult; Benzenesulfonates; Bile Acids and Salts; Cholesterol; Clinical Trials as Topic; Clofibrate; D | 1973 |
Liver scan in hyperlipoproteinemia.
Topics: Adult; Aged; Aspartate Aminotransferases; Blood Protein Disorders; Blood Protein Electrophoresis; Ch | 1974 |
[Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
Topics: Adult; Aged; Aluminum; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Drug Evalu | 1974 |
[The management of hyperlipoproteinemia with Liproreduct].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemia | 1974 |
[Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Ag | 1974 |
[Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Diet, Reducing; Drug Tolerance; Female; Humans; H | 1974 |
Fibrinolysis and platelet aggregation in the course of treatment with a combination of p-chlorophenoxyisobutyric acid derivatives in elderly arteriosclerotics.
Topics: Aged; Arteriosclerosis; Clofibrate; Drug Combinations; Female; Fibrinolysis; Humans; Hyperlipidemias | 1973 |
Clofibrate in coronary heart disease. Effect on morbidity and mortality.
Topics: Adult; Age Factors; Angina Pectoris; Blood Pressure; Cholesterol; Clofibrate; Coronary Disease; Huma | 1972 |
[Various internal medicine aspects of the future therapy for diabetic retinopathy].
Topics: Adult; Antineoplastic Agents; Azathioprine; Clofibrate; Diabetic Retinopathy; Female; Growth Hormone | 1972 |
Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
Topics: Adult; Anticholesteremic Agents; Blood Glucose; Cholesterol; Clofibrate; Diet Therapy; Female; Human | 1970 |
477 other studies available for clofibrate and Hyperlipemia
| Article | Year |
|---|---|
Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
Topics: Animals; Benzofurans; Cholesterol; Clofibrate; Cyclobutanes; Ethylmorphine-N-Demethylase; Hydroxymet | 1978 |
Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.
Topics: Animals; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Liver; Male; Polyethylene Glycols; Rats; | 1978 |
Hypolipidemic activity of phthalimide derivatives. 2. N-phenylphthalimide and derivatives.
Topics: Acetate-CoA Ligase; Acetyl-CoA Carboxylase; Acyltransferases; Animals; Cholesterol; Fatty Acid Synth | 1983 |
Hypolipidemic activity of phthalimide derivatives. 7. Structure-activity studies of indazolone analogues.
Topics: Animals; Hyperlipidemias; Hypolipidemic Agents; Indazoles; Male; Mice; Phthalimides; Structure-Activ | 1984 |
The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Benzodioxoles; Clofibric Acid; Dose- | 2021 |
Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.
Topics: 8,11,14-Eicosatrienoic Acid; Amino Acids; Animals; Clofibrate; Cytochrome P-450 CYP4A; Diabetes Mell | 2009 |
Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.
Topics: Animals; Anticholesteremic Agents; Clofibrate; Humans; Hyperlipidemias; Mice; Mice, Knockout; Muscle | 2013 |
Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
Topics: Androsterone; Anticoagulants; Butyrates; Clofibrate; Coronary Disease; Hypercholesterolemia; Hyperli | 1963 |
THE EFFECT OF ATROMID, AN ORALLY ACTIVE ANDROSTERONE ON SERUM LIPIDS IN NORMAL, HYPERCHOLESTEROLAEMIC AND HYPERLIPAEMIC SUBJECTS.
Topics: Androsterone; Aspartate Aminotransferases; Cholesterol; Clofibrate; Glycerides; Humans; Hypercholest | 1963 |
HYPERLIPAEMIC XANTHOMATOSIS TREATED WITH CLOFIBRATE. 'DRY DISCOID ECZEMA'.
Topics: Butyrates; Cholesterol; Clofibrate; Eczema; Humans; Hyperlipidemias; Triparanol; Xanthomatosis | 1964 |
THE TREATMENT OF XANTHOMATOSIS WITH ATROMID.
Topics: Androsterone; Blood Chemical Analysis; Butyrates; Clofibrate; Hypercholesterolemia; Hyperlipidemias; | 1964 |
[ATROMID IN HYPERCHOLESTEROLEMIA AND HYPERLIPEMIA. LITERATURE REVIEW AND RESULTS OF CLINICAL TESTS].
Topics: Androsterone; Biomedical Research; Butyrates; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidem | 1964 |
[THE ACTION OF CLOFIBRATE-ANDROSTERONE ON THE PLASMA CHOLESTEROL AND LIPIDS].
Topics: Androsterone; Butyrates; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Lip | 1964 |
THE TREATMENT OF XANTHOMATOSIS WITH "ATROMID".
Topics: Androsterone; Blood Chemical Analysis; Butyrates; Clofibrate; Drug Therapy; Hypercholesterolemia; Hy | 1964 |
THE EFFECT OF SF 20-10-5 CONCENTRATION CHANGES INDUCED BY ETHYL CHLOROPHENOXYISOBUTYRATE ON HIGH-DENSITY LIPOPROTEIN LIPID COMPOSITION.
Topics: Biochemical Phenomena; Biochemistry; Butyrates; Clofibrate; Glycerides; Hyperlipidemias; Lipid Metab | 1965 |
[EFFECT OF DEHYDROEPIANDROSTERONE AND ATROMID ON SERUM LIPIDS IN PATIENTS WITH HYPERCHOLESTEREMIA OR HYPERTRIGLYCERIDEMIA].
Topics: Androsterone; Butyrates; Clofibrate; Dehydroepiandrosterone; Humans; Hypercholesterolemia; Hyperlipi | 1965 |
A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
Topics: Androsterone; Anticholesteremic Agents; Butyrates; Clofibrate; Coronary Disease; Drug Therapy; Elect | 1965 |
The role of fibrates in a statin world.
Topics: Clofibrate; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperl | 2006 |
Hypolipidemic activity of Indan--1--acetic acids.
Topics: Acetates; Animals; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Hyperlipidemias; Hypolipidemic A | 2006 |
[Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits].
Topics: Animals; Cholesterol; Clofibrate; Drug Synergism; Fatty Acids, Nonesterified; Female; Heparin; Hyper | 1982 |
[Effect of clofibride on the lipolysis of perirenal adipose tissue in hyperlipemic rabbits].
Topics: Adipose Tissue; Animals; Clofibrate; Cosyntropin; Female; Hyperlipidemias; Hypolipidemic Agents; Ins | 1982 |
Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis.
Topics: Adolescent; Adult; Arteriosclerosis; Clofibrate; Dipyridamole; Female; Glomerulonephritis; Humans; H | 1984 |
Consensus conference: Treatment of hypertriglyceridemia.
Topics: Body Weight; Cardiovascular Diseases; Clofibrate; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipopro | 1984 |
Hyperlipidemia: reducing the chances of cardiovascular disease.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemia | 1984 |
[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
Topics: Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Time Factors; Uric Acid | 1983 |
Effect of Aloe barbedensis & clofibrate on serum lipids in triton-induced hyperlipidaemia in Presbytis monkeys.
Topics: Aloe; Animals; Cercopithecidae; Clofibrate; Hyperlipidemias; Lipids; Male; Plants, Medicinal; Polyet | 1983 |
Mechanism of cholesterol gallstones formation.
Topics: Animals; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Cholesterol | 1983 |
[Improvement in diabetes control by treatment with bezafibrate].
Topics: Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Diabetes Complications; Diabetes Mellitu | 1982 |
[Bezafibrate and delayed action etofibrate in hyperlipidemia].
Topics: Bezafibrate; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Clofibric Aci | 1983 |
Pharmacologic therapy for the hyperlipidemic patient.
Topics: Bile Acids and Salts; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Ni | 1983 |
Effect of KC-9432, a new hypolipidemic compound, on high density lipoprotein cholesterol in rats.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholic Acids; Clofibrate; Hyperlipidemias; Hypolipidemic Age | 1980 |
Studies on hypoxic dyslipidaemia. Effect of lipid modulating drugs.
Topics: Altitude; Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Decompression; Femal | 1982 |
[Hypolipidemic treatment in renal insufficiency].
Topics: Adolescent; Adult; Clofibrate; Female; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middl | 1981 |
[Bezafibrate in primary hyperlipidemias (author's transl)].
Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Clofibric Acid; Female; Hu | 1982 |
Effects of pantethine on different models of experimental hyperlipidemia in rodents: a comparison with clofibrate.
Topics: Animals; Clofibrate; Disease Models, Animal; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, HD | 1982 |
Treatment of uremic hypertriglyceridaemia with bezafibrate.
Topics: Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipidemias; Kidney Failur | 1982 |
Clofibrate in the management of hyperlipidaemia.
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1982 |
Lipid-lowering effects of N-[4-methylbenzylthiocarbonyl]-L-phenylalanine (KF1492), a new phenylalanine derivative.
Topics: Animals; Cholesterol; Clofibrate; Diet; Glycerol; Hyperlipidemias; Hypolipidemic Agents; Male; Pheny | 1982 |
The spontaneously hyperlipidemic old rat as a model for evaluation of hypolipoproteinemic drugs. Effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
Topics: Aging; Animals; Cholesterol; Clofibrate; Drug Evaluation, Preclinical; Hyperlipidemias; Lipoproteins | 1982 |
Hypolipidemic effects of S-methylmethionine (vitamin U) using various experimental procedures.
Topics: Animals; Catalase; Clofibrate; Diet; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein Lipase; Live | 1980 |
[Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Topics: Animals; Body Weight; Clofibrate; Diet; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Rats | 1980 |
[Clinical effects and tolerance of etofylline clofibrate].
Topics: Clofibrate; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hy | 1980 |
[Effect of bezafibrate on the carbohydrate metabolism of 17 diabetics with hyperlipidemia].
Topics: Anticholesteremic Agents; Bezafibrate; Body Weight; Carbohydrate Metabolism; Clofibrate; Clofibric A | 1981 |
[Hypolipidemic action of simfibrate in diabetic subjects].
Topics: Adult; Aged; Clofibrate; Diabetes Complications; Female; Humans; Hyperlipidemias; Hypolipidemic Agen | 1981 |
Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models.
Topics: Animals; Anticholesteremic Agents; Benzopyrans; Chromans; Chromones; Clofibrate; Disease Models, Ani | 1981 |
[Study of clofibrate. The opinion of Prof. D. Kritchevsky].
Topics: Adult; Arteriosclerosis; Cholelithiasis; Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hype | 1980 |
Metabolic disorders associated with hyperlipemia: activity of an extremely potent hypolipemic agent (LR 19731).
Topics: Animals; Cholesterol; Clofibrate; Dioxoles; Dose-Response Relationship, Drug; Female; Fenofibrate; H | 1981 |
Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
Topics: Adult; Bile; Cholesterol; Clofibrate; Deoxycholic Acid; Drug Therapy, Combination; Female; Humans; H | 1981 |
Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia.
Topics: Adult; Arteriosclerosis; Clofibrate; Coronary Disease; Fibrinogen; Garlic; Humans; Hyperlipidemias; | 1981 |
Clinical importance of clofibrate induced increase of creatine kinase catalytic activity concentration in serum.
Topics: Clofibrate; Creatine Kinase; Humans; Hyperlipidemias; Male; Middle Aged; Muscular Diseases | 1981 |
[Therapy of hypertriglyceridemia from a pathophysiological viewpoint].
Topics: Clofibrate; Diet, Reducing; Drug Combinations; Exercise Therapy; Humans; Hyperlipidemias; Phospholip | 1981 |
Significant and persistent reduction of serum lipids in asymptomatic men.
Topics: Cholesterol; Clofibrate; Coronary Disease; Follow-Up Studies; Humans; Hyperlipidemias; Lipids; Male; | 1981 |
[Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)].
Topics: Abnormalities, Drug-Induced; Animals; Clofibrate; Clofibric Acid; Diet, Atherogenic; Dogs; Female; F | 1980 |
Clinical pharmacokinetics of bezafibrate in patients with impaired renal function.
Topics: Adult; Aged; Bezafibrate; Clofibrate; Clofibric Acid; Creatinine; Female; Humans; Hyperlipidemias; H | 1981 |
[Comparative evaluation of beta-benzalbutyramide and clofibrate in the short-term treatment of hyperlipidemic patients].
Topics: Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Hypolipidemic Agents; Phenylbutyrates; Random | 1981 |
Therapeutic drug assays with gas-liquid chromatography and optical detection.
Topics: Chromatography, Gas; Clofibrate; Humans; Hyperlipidemias | 1981 |
In vitro cholesterol synthesis in freshly isolated mononuclear cells of human blood: effect of in vivo administration of clofibrate and/or cholestyramine.
Topics: Cell Separation; Cholesterol; Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Lymphocytes | 1980 |
Management of the hyperlipidaemias.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Female; Humans; Hyperlipidemias; Nicotinic Acids | 1980 |
Effects of combined procetofene--nicotinic acid therapy in treatment of hypertriglyceridaemia.
Topics: Aged; Cholesterol; Clofibrate; Drug Therapy, Combination; Fenofibrate; Humans; Hyperlipidemias; Lipo | 1980 |
[Drug therapy of hyperlipidemic states].
Topics: Adolescent; Adult; Cholestyramine Resin; Clofibrate; Drug Evaluation; Female; Humans; Hyperlipidemia | 1980 |
[Hypolipemic effectiveness of using miskleron in diabetes mellitus in children and adolescents with lipodystrophies].
Topics: Adolescent; Child; Clofibrate; Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Type 1; Drug Eval | 1980 |
Drug treatment of hyperlipidemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperli | 1980 |
[Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Clofibrate; Female; Humans; Hyperlipidemias; Middle Aged; Phenformin; | 1980 |
Hyperlipidaemia advances and retreats.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Lipoprotei | 1980 |
Hyperlipidaemia advances and retreats.
Topics: Clofibrate; Humans; Hyperlipidemias | 1980 |
[Hypolipidaemic agents (author's transl)].
Topics: Animals; Chemical Phenomena; Chemistry; Cholesterol; Cholestyramine Resin; Clofibrate; Humans; Hyper | 1980 |
[Undesirable effects of hypolipemic drugs].
Topics: Adult; Arrhythmias, Cardiac; Avitaminosis; Biliary Tract Diseases; Cholestyramine Resin; Clofibrate; | 1980 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; | 1980 |
Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations.
Topics: Aged; Apoproteins; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Male | 1980 |
Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
Topics: Carrier Proteins; Cholesterol Ester Transfer Proteins; Chylomicrons; Clofibrate; Eating; Female; Gly | 1995 |
The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats.
Topics: Animals; Anticholesteremic Agents; Azathioprine; CD4-Positive T-Lymphocytes; Cholestyramine Resin; C | 1996 |
High death rate from neoplasms in French diabetic and non-diabetic men.
Topics: Case-Control Studies; Clofibrate; Diabetes Mellitus; Humans; Hyperlipidemias; Hypolipidemic Agents; | 1998 |
Lipid-lowering drug use and cardiovascular events after myocardial infarction.
Topics: Cholesterol; Clofibrate; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Humans; | 2002 |
[Field study on the decrease of lipids using etofibrate].
Topics: Alanine Transaminase; Anticholesteremic Agents; Aspartate Aminotransferases; Cholesterol; Clofibrate | 1976 |
Selective effects of clofibrate on alkaline phosphatase isoenzymes in serum.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Clofibrate; Female; gamma-Glutamyltransferase; Humans; | 1979 |
Editorial: Lipid-lowering drugs after myocardial infarction.
Topics: Cholesterol; Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Myocardial Infarctio | 1975 |
Letter: Reduction of serum-alkaline-phosphatase by clofibrate.
Topics: Alkaline Phosphatase; Clofibrate; Humans; Hyperlipidemias | 1975 |
Plasma exchange in the management of homozygous familial hypercholesterolaemia.
Topics: Adult; Aortic Diseases; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Di | 1975 |
[The importance of platelet function for the detection of thrombosis susceptibliity].
Topics: Blood Platelet Disorders; Blood Platelets; Clofibrate; Contraceptives, Oral; Coronary Disease; Densi | 1975 |
Clofibrate-induced muscle damage in patients with chronic renal failure.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Butyrates; Cholesterol; Clofibrate; Creati | 1975 |
Letter: Acute-on-chronic renal failure precipitated by clofibrate.
Topics: Acute Kidney Injury; Adult; Clofibrate; Female; Humans; Hyperlipidemias; Kidney Failure, Chronic; Ma | 1976 |
Chenodeoxycholic acid for hypertriglyceridaemia.
Topics: Chenodeoxycholic Acid; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Male; Middle Aged; Trig | 1976 |
Myokymia, unusual side-effect of clofibrate.
Topics: Clofibrate; Humans; Hyperlipidemias; Male; Middle Aged; Neuromuscular Diseases | 1976 |
Clofibrate-induced increase in serum-creatine-phosphokinase level.
Topics: Clofibrate; Creatine Kinase; Humans; Hyperlipidemias; Male; Middle Aged | 1977 |
Clofibrate increases lipoprotein-lipase activity in adipose tissue of hypertriglyceridaemic patients.
Topics: Adipose Tissue; Adult; Clofibrate; Heparin; Humans; Hyperlipidemias; In Vitro Techniques; Lipoprotei | 1977 |
Hypolipidaemic agents: What are they good for?
Topics: Cholesterol; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, | 1977 |
Clofibrate and the liver.
Topics: Animals; Clofibrate; Humans; Hyperlipidemias; Liver; Rats | 1978 |
Clofibrate.
Topics: Bile Acids and Salts; Clofibrate; Colonic Neoplasms; Coronary Disease; Drug Evaluation; Humans; Hype | 1978 |
Effect of treatment of hypertriglyceridaemia on high and low density lipoprotein cholesterol concentrations.
Topics: Adult; Aged; Cholesterol; Clofibrate; Dietary Carbohydrates; Dietary Fats; Humans; Hyperlipidemias; | 1979 |
[Selective lipid therapy].
Topics: Arteriosclerosis; Clofibrate; Hyperlipidemias; Kidney Diseases; Lipoproteins | 1978 |
[Clofibrate banned - what now? (author's transl)].
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Diet, Reducing; Drug and Narcotic Contro | 1979 |
[A reinstatement of clofibrate appears justified].
Topics: Clofibrate; Germany, West; Humans; Hyperlipidemias; Legislation, Drug; Lipids | 1979 |
Effect of long term treatment with hydrophilic colloid on serum lipids.
Topics: Adult; Aged; Cholesterol; Clofibrate; Colloids; Dietary Fiber; Female; Humans; Hyperlipidemias; Long | 1979 |
Biliary lipid composition during treatment with different hypolipidaemic drugs.
Topics: Adult; Aged; Bile; Cholesterol; Cholestyramine Resin; Clofibrate; Female; Humans; Hyperlipidemias; L | 1979 |
[Lipid metabolism disorders and deafness of the inner ear. Therapeutic approaches: clinical testing of clofibrate (Lipavlon: I.C.I. Pharma laboratories)].
Topics: Clofibrate; Deafness; Drug Evaluation; Humans; Hyperlipidemias | 1977 |
[Familial type V hyperlipoproteinemia].
Topics: Clofibrate; Humans; Hyperlipidemias; Lipoproteins, VLDL; Nicotinic Acids | 1975 |
Antihyperlipidaemic agents.
Topics: Animals; Cholesterol; Chylomicrons; Clofibrate; Dogs; Electrophoresis, Polyacrylamide Gel; Fatty Aci | 1975 |
[Serum lipid-lowering drugs following myocardial infarction].
Topics: Cholesterol; Clofibrate; Dextrothyroxine; Estrogens, Conjugated (USP); Female; Germany, West; Humans | 1975 |
The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
Topics: Adult; Blood Protein Electrophoresis; Clofibrate; Dietary Carbohydrates; Dietary Fats; Electrophores | 1975 |
Should hyperlipoproteinemia be treated in patients with coronary artery disease?
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Body Weight; Cholestyramine Resin; Clofibrate; Coronary D | 1975 |
Lp(a) lipoprotein: relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B.
Topics: Adult; Aged; Apoproteins; Clofibrate; Contraceptives, Oral; Dietary Carbohydrates; Dietary Fats; Die | 1975 |
[Efficiency of clofibrate in chronic dialysis patients with hyperlipoproteinemia].
Topics: Clofibrate; Half-Life; Humans; Hyperlipidemias; Lipoproteins, VLDL; Long-Term Care; Renal Dialysis; | 1975 |
[Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
Topics: Adult; Age Factors; Aged; Chylomicrons; Clofibrate; Diabetes Complications; Drug Therapy, Combinatio | 1975 |
Experimental and clinical evaluation of two "Atromid-S" analogues in relation to their differential modes of action.
Topics: Animals; Body Weight; Butyrates; Clofenapate; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterif | 1975 |
Pathogenesis of hyperlipidemias, clues to treatment?
Topics: Animals; Cholesterol; Clofibrate; Colchicine; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Musc | 1975 |
[Mixed hyperlipidemia resistant to ordinary dietetic and medical treatment. 30 cases].
Topics: Adult; Aged; Cardiovascular Diseases; Clofibrate; Female; Glucose; Humans; Hyperlipidemias; Lipoprot | 1975 |
[Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
Topics: Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, LDL; Triglycerides | 1975 |
[Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
Topics: Administration, Oral; Blood Glucose; Body Weight; Cholesterol; Clofibrate; Glucose; Glucose Toleranc | 1976 |
Hyperlipidemic neuropathy and dementia.
Topics: Adult; Cholesterol; Chylomicrons; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Li | 1976 |
Intermittent cerebral symptoms in type V hyperlipoproteinemia.
Topics: Adult; Brain Diseases; Chylomicrons; Clofibrate; Headache; Humans; Hyperlipidemias; Lipoproteins, VL | 1976 |
Dietary and drug treatment of hyperlipidaemia. A feasibility study in asymptomatic middle-aged men.
Topics: Body Weight; Cholesterol; Clofibrate; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipidemi | 1976 |
Zero electrophoretic mobility of very low density lipoproteins in type III hyperlipidemic patients during treatment.
Topics: Adult; Clofibrate; Electrophoresis, Paper; Female; Humans; Hyperlipidemias; Lipids; Lipoproteins, VL | 1976 |
[Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
Topics: Adult; Aged; Arthritis, Rheumatoid; Cholesterol; Clofibrate; Drug Therapy, Combination; Female; Glyc | 1975 |
[Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
Topics: Cholesterol; Chylomicrons; Clofibrate; Coronary Disease; Drug Evaluation; Female; Humans; Hyperlipid | 1976 |
Chylomicron clearance in normal and hyperlipidemic man.
Topics: Adult; Cholesterol; Chylomicrons; Clofibrate; Dietary Fats; Fasting; Humans; Hyperlipidemias; Lipids | 1976 |
Pediatric familial type III hyperlipoproteinemia.
Topics: Adolescent; Adult; Cholesterol; Clofibrate; Diet, Reducing; Female; Humans; Hyperlipidemias; Lipopro | 1976 |
[Hyperlipemia: practical attitudes].
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diabetes Complications; Energy Metabolism; Feeding Be | 1976 |
Changes produced by clofibrate in hepatocytes of rats with sucrose-induced hyperlipidemia.
Topics: Animals; Clofibrate; Endoplasmic Reticulum; Glycogen; Golgi Apparatus; Hyperlipidemias; Lipoproteins | 1976 |
On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Topics: Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins | 1977 |
Effect of clofibrate treatment on chronic hyperlipidemia induced by an ACTH-producing tumor.
Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Cholesterol; Clofibrate; Growth Hormone; Hyperlip | 1977 |
[The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
Topics: Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Inositol; Lipoproteins, HDL; Lipoproteins, L | 1976 |
[The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
Topics: Cholesterol; Clofibrate; Drug Therapy, Combination; Humans; Hyperlipidemias; Lipoproteins, LDL; Phen | 1976 |
[Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Topics: Adult; Aged; Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins; Lipoproteins, HDL; Lipo | 1977 |
[Secondary hyperlipoproteinemias].
Topics: Acute Disease; Clofibrate; Female; Hepatitis; Humans; Hyperlipidemias; Hypothyroidism; Lipoproteins, | 1977 |
Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.
Topics: Apolipoproteins; Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, | 1978 |
Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.
Topics: Adult; Apolipoproteins; Clofibrate; Diet; Female; Humans; Hyperlipidemias; Iodine Radioisotopes; Kin | 1978 |
[The when and how of therapy for hyperlipoproteinemia].
Topics: Arteriosclerosis; Cholesterol; Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Lipoproteins, | 1978 |
[Constellation of lipoproteins in patients with hyperlipoproteinemia and in rabbits fed a cholesterol diet with reference to vascular permeability].
Topics: Animals; Capillary Permeability; Cholesterol; Cholesterol, Dietary; Clofibrate; Female; Humans; Hype | 1977 |
Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Topics: Cholesterol; Clofibrate; Dietary Carbohydrates; Humans; Hyperlipidemias; Lipoproteins; Lipoproteins, | 1977 |
[Treatment of type IV and V hyperlipemia--personal experiences].
Topics: Adult; Anticholesteremic Agents; Cholesterol; Chylomicrons; Clofibrate; Female; Humans; Hyperlipidem | 1978 |
[Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
Topics: Adult; Cholesterol; Clofibrate; Diet Therapy; Energy Intake; Female; Humans; Hyperlipidemias; Lipopr | 1978 |
[Treatment of hyperlipemia with tibric acid (TA)].
Topics: Adult; Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, VLDL; Middle Aged; Piperidine | 1978 |
Combined effects of clofibrate and diosgenin on cholesterol metabolism in rats.
Topics: Absorption; Animals; Anticholesteremic Agents; Biological Availability; Cholesterol; Clofibrate; Dru | 1978 |
Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteins.
Topics: Acetamides; Animals; Arteriosclerosis; Cholesterol; Clofibrate; Dogs; Dose-Response Relationship, Dr | 1978 |
Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Clofibrate; Disease Models, Animal; Dose-Response Relati | 1978 |
Uremic hyperlipidemia: the nature of the problem.
Topics: Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, HDL; Renal Dialysis; Uremia | 1977 |
Lecithin:cholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and clofibrate treatment of hypertriglyceridemic subjects.
Topics: Body Weight; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, HDL; Phosphatidylcholine-Sterol O-Ac | 1978 |
Platelet function in thrombosis and atherosclerosis.
Topics: Adenylyl Cyclases; Arteriosclerosis; Blood Platelets; Cell Membrane; Clofibrate; Cyclic AMP; Halofen | 1978 |
Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
Topics: Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Humans; Hyperlipidemias; Hypolipidemic Ag | 1978 |
One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Topics: Cholesterol; Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, | 1978 |
Influence of clofibrate on blood viscosity in primary hyperlipoproteinemia.
Topics: Blood Viscosity; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; | 1979 |
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Topics: Cholestyramine Resin; Clofibrate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Human | 1975 |
Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Topics: Adult; Apolipoproteins; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; | 1979 |
[Hyperlipoproteinemia].
Topics: Adipose Tissue; Apolipoproteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Fatty | 1979 |
Treating lipid disorders.
Topics: Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hypercholesterolemia; Hyperlipidemias; Hypoli | 1979 |
[Type V hyperlipemia. 54 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Alcoholism; Blood Protein Electrophoresis; Child; Child, Preschool; Cholest | 1979 |
Effect of hypolipidemic drugs on serum lipoproteins.
Topics: Aged; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Humans; | 1979 |
Experimental hyperlipidemia in rats.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Animals; Blood Pressure; Cholesterol; Clofibrate; Cycli | 1979 |
[Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
Topics: Adult; Aged; Cholesterol; Clofibrate; Drug Evaluation; Drug Tolerance; Evaluation Studies as Topic; | 1979 |
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
Topics: Adipose Tissue; Cholesterol; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Lipoprotein Lipas | 1979 |
Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Cholic Acids; Clofibrate; Deoxycholic Acid; Diet; Di | 1975 |
The value of clofibrate.
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1978 |
Effect of clofibrate on intravascular coagulation in hyperlipoproteinemia.
Topics: Antithrombins; Aprotinin; Arteriosclerosis; Clofibrate; Disseminated Intravascular Coagulation; Fact | 1977 |
[Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
Topics: Adult; Aged; Clofibrate; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Humans; Hyper | 1979 |
Ileal bypass in the control of hyperlipidemia and atherosclerosis.
Topics: Adult; Animals; Aorta; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary | 1978 |
Increase of the lipoprotein-lipase activity in human skeletal muscle during clofibrate administration.
Topics: Adipose Tissue; Adult; Clofibrate; Female; Glucagon; Humans; Hyperlipidemias; Insulin; Lipoprotein L | 1978 |
Management of hyperlipidemia in diabetes.
Topics: Cholestyramine Resin; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Humans; Hyperch | 1979 |
Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats.
Topics: Animals; Blood Proteins; Clofibrate; Drug Interactions; Half-Life; Hyperlipidemias; Hypolipidemic Ag | 1979 |
Corrigendum.
Topics: Clofibrate; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias | 1979 |
[Correction of lipid exchange with heparin and miscleron in patients with ischemic heart disease].
Topics: Adult; Clofibrate; Female; Heparin; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarctio | 1979 |
The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Cholesterol; Clofibrate; Cyclopropanes; Dru | 1979 |
Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy.
Topics: Adult; Aged; Arteriosclerosis; Blood Platelets; Clofibrate; Female; Humans; Hyperlipidemias; Kinetic | 1979 |
[Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Germany, West; Humans; Hyperlipidemias; Hypolipidemic | 1979 |
Hyperlipoproteinemia induced by a transplantable pituitary tumor in the rat.
Topics: Animals; Body Weight; Cholesterol; Clofibrate; Electrophoresis, Agar Gel; Electrophoresis, Polyacryl | 1979 |
[Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
Topics: Administration, Oral; Adult; Cholesterol; Clofibrate; Drug Evaluation; Humans; Hypercholesterolemia; | 1979 |
New label restrictions and boxed warning on clofibrate.
Topics: Clofibrate; Drug Labeling; Humans; Hyperlipidemias; United States; United States Food and Drug Admin | 1979 |
[The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Topics: Aged; Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle A | 1979 |
[Clofibrate--helpful or harmful?].
Topics: Adult; Cholecystitis; Cholesterol; Clofibrate; Coronary Disease; Germany, West; Humans; Hyperlipidem | 1979 |
[Lipid decreasing effect of trans-2,10-dichloro-6-ethoxycarbonyl-12-methyldibenzo[d,g] [1,3]dioxocin (EGYT-1932, Crismel)].
Topics: Animals; Clofibrate; Heterocyclic Compounds; Hyperlipidemias; Hypolipidemic Agents; Rats | 1979 |
[Clofibrate--overreaction?].
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1979 |
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
Topics: Animals; Clofibrate; Clofibric Acid; Diet; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; | 1979 |
[Atherosclerosis, hyperlipidemia and clofibrate].
Topics: Arteriosclerosis; Clofibrate; Humans; Hyperlipidemias | 1979 |
[Hyperlipoproteinemia in general practice. Occurrence, type pattern and risk profile of hyperlipidemic patients].
Topics: Clofibrate; Diet Therapy; Female; Germany, West; Humans; Hyperlipidemias; Lipids; Male; Nicotinic Ac | 1979 |
[The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
Topics: Arteriosclerosis; Clofibrate; Coronary Disease; Humans; Hypercholesterolemia; Hyperlipidemias; Myoca | 1979 |
[Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
Topics: Clofibrate; Fatty Alcohols; Gastrointestinal Diseases; Headache; Humans; Hyperlipidemias; Hyperlipop | 1979 |
[Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].
Topics: Adult; Aged; Clofibrate; Diabetes Complications; Fatty Alcohols; Female; Humans; Hyperlipidemias; Hy | 1979 |
[Clinical study with a new antihyperlipemic combination].
Topics: Adult; Aged; Blood Pressure; Cholesterol; Clofibrate; Drug Combinations; Female; Hemostasis; Humans; | 1977 |
Platelet function in hyperbetalipoproteinemia.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Blood Platelets; Clofibrate; Halofenate; Humans; Hyperlipi | 1978 |
Hypolipidemic effects of S-methylmethionine (vitamin U) using various experimental procedures.
Topics: Animals; Cholesterol; Clofibrate; Dietary Fats; Hyperlipidemias; Lipid Metabolism; Lipids; Rabbits; | 1978 |
Clofibrate treatment of hyperlipidemia in chronic renal failure.
Topics: Adult; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipids; Ma | 1977 |
A practical guide to hyperlipidaemic disorders.
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids | 1977 |
[Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)].
Topics: Blood Viscosity; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipidemias; Male; Mid | 1978 |
[Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
Topics: Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemias; Male; Middle Aged; Nicotinyl Alcohol | 1978 |
Hypolipidemic drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins | 1978 |
The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern.
Topics: Adult; Cholesterol; Chylomicrons; Clofibrate; Contraceptives, Oral; Contraceptives, Oral, Combined; | 1978 |
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextr | 1978 |
[The treatment of hypertriglyceridemia].
Topics: Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemias; Male; Nicotinyl Alcohol; Pyridines; | 1978 |
Animal models for screening hypolipidemic agents. I. Response to clofibrate in NMRI-mice of different body-weights.
Topics: Animals; Body Weight; Clofibrate; Disease Models, Animal; Drug Evaluation, Preclinical; Hyperlipidem | 1978 |
Animal models for screening hypolipidemic drugs. III. The response of nicotinic acid and clofibrate in fed and fasted old rats.
Topics: Age Factors; Animals; Clofibrate; Disease Models, Animal; Drug Evaluation, Preclinical; Fasting; Hyp | 1978 |
Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.
Topics: Adult; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol; Clofibrate; Drug Therapy, Com | 1978 |
[An unusual case of hyperlipoproteinemia type III manifestation].
Topics: Aged; Clofibrate; Humans; Hyperlipidemias; Immunoglobulin A; Male; Multiple Myeloma; Xanthomatosis | 1978 |
Effect of clofibrate on in vivo triglyceride production and clearance in genetically hyperlipemic rats.
Topics: Animals; Clofibrate; Female; Hyperlipidemias; Liver; Metabolic Clearance Rate; Obesity; Rats; Trigly | 1978 |
Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Drug Evaluation; Female; Humans; Hyperlipidemias; | 1978 |
Plasma protein concentrations in hypertriglyceridaemic subjects. Effect of clofibrate and comparison with normal subjects.
Topics: Adult; Blood Proteins; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins; Male; | 1978 |
[Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
Topics: Blood Glucose; Cholesterol; Clofibrate; Diabetes Complications; Diabetes Mellitus; Female; Glycosuri | 1978 |
Clofibrate therapy and gallstone induction.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Clofibrate; Female; Humans; Hy | 1978 |
[Treatment of hyperlipidemia].
Topics: Clofibrate; Humans; Hyperlipidemias | 1978 |
[Hypolipemic activity of ITA 104].
Topics: Animals; Clofibrate; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Mice; Rats | 1978 |
[Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Topics: Animals; Cholesterol; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Nicotinic Aci | 1978 |
[Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
Topics: Animals; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Nicotinic Acids; Ra | 1978 |
[Familial hypercholesteremia. Clinico-diagnostic and therapeutic aspects].
Topics: Adult; Aged; Child; Cholestyramine Resin; Clofibrate; Female; Humans; Hyperlipidemias; Male; Middle | 1978 |
Effect of guggulu (Commiphora mukul--Engl.) on serum lipids in obese, hypercholesterolemic and hyperlipemic cases.
Topics: Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Obesity; Plant Extr | 1978 |
[Atherosclerosis. Its implications, prevention and dietetic and pharmacological treatment].
Topics: Anticholesteremic Agents; Arteriosclerosis; Biguanides; Cholesterol; Cholestyramine Resin; Clofibrat | 1978 |
[Relationship between the manifestation of diabetes and the treatment of hyperlipemia].
Topics: Adult; Aged; Clofibrate; Diabetes Complications; Diabetes Mellitus; Energy Intake; Female; Humans; H | 1978 |
Image processing in pathology. VIII. Internal structure of mitochondria during treatment of HLP-patients with Regadrin.
Topics: Biopsy; Clofibrate; Electronic Data Processing; Humans; Hyperlipidemias; Liver; Mitochondria, Liver | 1978 |
The effect of riboflavin tetrabutyrate on lipoperoxide content of oils and experimental hyperlipaemia on rats and rabbits and its comparison with clofibrate.
Topics: Animals; Clofibrate; Hyperlipidemias; Lipids; Oils; Oxidation-Reduction; Rabbits; Rats; Riboflavin | 1978 |
Prevalence of gallstones in hyperlipidemia and incidence during treatment with clofibrate and/or cholestyramine.
Topics: Cholelithiasis; Cholestyramine Resin; Clofibrate; Dietary Fats; Drug Interactions; Humans; Hyperlipi | 1978 |
[Alternatives to clofibrate].
Topics: Clofibrate; Germany, West; Humans; Hyperlipidemias; Legislation, Drug | 1979 |
[Bezafibrate is not the same as clofibrate].
Topics: Clofibrate; Hyperlipidemias | 1979 |
[Is primary or secondary prevention of diabetes mellitus in hyperliporoteinemia possible under long-term clofibrate therapy?].
Topics: Clofibrate; Diabetes Mellitus; Humans; Hyperlipidemias; Long-Term Care; Middle Aged; Time Factors | 1976 |
[Clofibrate treatment of hyperlipidemia in long-term dialysis patients].
Topics: Clofibrate; Humans; Hyperlipidemias; Kidney Failure, Chronic; Long-Term Care; Renal Dialysis | 1976 |
The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Topics: Animals; Cholesterol; Clofibrate; Depression, Chemical; Female; Haplorhini; Hyperlipidemias; Hypolip | 1976 |
Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; F | 1977 |
Untoward effects of clofibrate in hemodialyzed patients.
Topics: Clofibrate; Humans; Hyperlipidemias; Muscular Diseases; Renal Dialysis; Uremia | 1977 |
Control of clofibrate toxicity in uremic hypertriglyceridemia.
Topics: Adult; Cholesterol; Clofibrate; Creatine Kinase; Dose-Response Relationship, Drug; Drug Administrati | 1977 |
Clofibrate in hemodialyzed patients.
Topics: Clofibrate; Humans; Hyperlipidemias; Male; Renal Dialysis | 1977 |
Lack of effect of two pectins in idiopathic or gout-associated hyperdyslipidemia hypercholesterolemia.
Topics: Citrus; Clofibrate; Fruit; Gout; Hypercholesterolemia; Hyperlipidemias; Lipids; Pectins; Structure-A | 1977 |
Supplementation with vitamin E in hyperlipidemic patients treated with diet and clofibrate. Effects on serum lipoprotein concentrations, plasma fatty acid composition and adipose tissue lipoprotein lipase activity.
Topics: Adipose Tissue; Aged; Cholesterol Esters; Clofibrate; Fatty Acids; Fatty Acids, Unsaturated; Female; | 1977 |
Comparison of assay methods for selective measurement of plasma lipase. The effect of clofibrate on hepatic and lipoprotein lipase in normals and patients with hypertriglyceridemia.
Topics: Adolescent; Adult; Aged; Clofibrate; Humans; Hyperlipidemias; Lipase; Lipoprotein Lipase; Liver; Met | 1977 |
[Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
Topics: Adult; Aged; Cholesterol; Clofibrate; Decanoates; Drug Evaluation; Drug Tolerance; Fatty Alcohols; F | 1977 |
[Potency disorders during the therapy or metabolic diseases].
Topics: Clofibrate; Erectile Dysfunction; Humans; Hyperlipidemias; Male | 1977 |
Clofibrate effect on alkaline phosphatase in renal failure.
Topics: Alkaline Phosphatase; Bone and Bones; Clofibrate; Humans; Hyperlipidemias; Isoenzymes; Kidney Failur | 1977 |
[Hypolipidemic efficacy of clofibrate preparations (atromid C, atromidine, mixleron) in coronary atherosclerosis with different types of hyperlipoproteinemia].
Topics: Aged; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Middle Aged | 1977 |
[Indications, contraindications and adverse effects of drugs in cardiovascular diseases. Treatment of hyperlipoproteinemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Myocardial Infarction; Nicotinic Acids | 1977 |
[Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
Topics: Anticholesteremic Agents; Blood Platelet Disorders; Cholestyramine Resin; Clofibrate; Humans; Hyperc | 1977 |
The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia.
Topics: Adult; Cholesterol; Chromatography, Affinity; Clofibrate; Drug Evaluation; Heparin; Humans; Hyperlip | 1977 |
Effects of clofibrate on cholesterol metabolism.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Clofibrate; Diet; Feces; Femal | 1977 |
[Effect of miscleron on various indicators of blood coagulation in ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Male; | 1977 |
[Drug treatment of hyperlipoproteinemias].
Topics: Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Erectile Dysfunction; Female; Humans; Hyp | 1977 |
Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Topics: Animals; Benzofurans; Chemical Phenomena; Chemistry; Clofibrate; Drug Evaluation, Preclinical; Hyper | 1977 |
[Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
Topics: Cholesterol; Clofibrate; Diabetes Complications; Diabetes Mellitus; Dietary Fats; Fatty Acids, Nones | 1977 |
Results of treatment of hyperlipidemias; short term effect on cholesterol metabolism.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Cholesterol; Clofibrate; Diet, Reducing; Female; Humans | 1977 |
Results of treatment of hyperlipidemias: long-term compliance and effect of lipid metabolism.
Topics: Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hy | 1977 |
The drug treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Drug Therapy, Combination; Humans; Hyperlipidemias; Nicotinic Acid | 1977 |
Long term clinical studies on the hypolipidaemic effect of Commiphora mukul (Guggulu) and clofibrate.
Topics: Adult; Clofibrate; Female; Humans; Hyperlipidemias; Male; Plant Extracts; Plants, Medicinal | 1977 |
[Effects of various modes of therapy on the fatty acid spectrum in hyperlipoproteinemia].
Topics: Cholesterol; Clofibrate; Fatty Acids; Humans; Hyperlipidemias; Nicotinyl Alcohol; Triglycerides; Xan | 1977 |
[Hyperlipidemias. Diet and drug therapy].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine | 1977 |
Dextrothyroxine for lowering cholesterol.
Topics: Angina Pectoris; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hypercholesterolemia; Hy | 1976 |
A pathophysiologic approach to managing hyperlipemia.
Topics: Adult; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Lipid Me | 1976 |
Drug therapy of hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Drug Therap | 1976 |
[Treatment of hyperlipidemia].
Topics: Adult; Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male | 1976 |
Therapy of the hyperlipidemias.
Topics: Anticoagulants; Blood Platelets; Child; Cholesterol; Chylomicrons; Clofibrate; Diet, Reducing; Drug | 1976 |
Regression of atherosclerotic stenosing lesions of the renal arteries and spontaneous cure of systemic hypertension through control of hyperlipidemia.
Topics: Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Female; Humans; Hyperlipidemias; Hy | 1976 |
Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
Topics: Animals; Anticholesteremic Agents; Ascorbic Acid; Cholesterol; Clofibrate; Dose-Response Relationshi | 1976 |
[Treatment of hyperlipoproteinemia].
Topics: Adult; Clofibrate; Dextrothyroxine; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Mid | 1976 |
[About the further development of a 6 year old boy with essential hyperlipaemia (fat induced hypertriglyceridaemia)].
Topics: Adolescent; Adult; Clofibrate; Diet; Feeding Behavior; Female; Follow-Up Studies; Humans; Hyperlipid | 1976 |
Fundus changes in primary hyperlipaemia.
Topics: Adult; Chylomicrons; Clofibrate; Eye Manifestations; Fundus Oculi; Humans; Hyperlipidemias; Male; Re | 1976 |
Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
Topics: Animals; Cholesterol; Clofibrate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; H | 1976 |
[Diabetic nephropathy, hypothyroidism and colfibrate-induced myopathy (author's transl)].
Topics: Adult; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabet | 1976 |
[Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)].
Topics: Adolescent; Adult; Aged; Aluminum; Blood Group Antigens; Cholesterol; Clofibrate; Female; HLA Antige | 1976 |
[Medium and long term study of clofibride in the treatment of atherogenic hyperlipidemia. Statistical approach to the results].
Topics: Adult; Aged; Amides; Arteriosclerosis; Clofibrate; Drug Evaluation; Female; Humans; Hyperlipidemias; | 1976 |
[Experimentation with Atherulip 500 (apropos of 30 cases)].
Topics: Adult; Aged; Clofibrate; Drug Evaluation; Female; Humans; Hyperlipidemias; Male; Middle Aged | 1976 |
[Effect of clofibrate therapy on the glucagon and insulin secretion as well as on the glucose tolerance in patients with type IV hyperlipoproteinemia].
Topics: Clofibrate; Glucagon; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Secretion | 1976 |
Differential drug therapy of the hyperlipoproteinaemias. The efficacy of lipid lowering drugs alone and in combination.
Topics: Cholesterol; Clofibrate; Drug Synergism; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolip | 1975 |
Hyperlipidemia: to treat or not to treat.
Topics: Cerebrovascular Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyper | 1975 |
Letter: Screening for hyperlipidaemia in childhood.
Topics: Age Factors; Blood; Cholesterol; Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Infant, | 1975 |
Effect of cholestyramine on tissue pools of cholesterol a preliminary report.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyp | 1975 |
Lipid-lowering drugs.
Topics: Cellulose; Cholestyramine Resin; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Lipids; Myoca | 1975 |
Assay of clofibrate in human serum by gas chromatography.
Topics: Chromatography, Gas; Clofibrate; Humans; Hyperlipidemias; Phenoxyacetates; Propionates | 1975 |
[Hyperlipoproteinemias in internal medicine and therapeutic possibilities].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine | 1975 |
Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
Topics: Adult; Antigens; Arginine; Blood Glucose; Cholesterol; Clofibrate; Fasting; Fatty Acids, Nonesterifi | 1975 |
Some aspects of the management of the hyperlipidaemias.
Topics: Anion Exchange Resins; Clofibrate; Fats, Unsaturated; Humans; Hypercholesterolemia; Hyperlipidemias; | 1975 |
The investigation and treatment of hyperlipidaemia in general practice.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Reducing; Family Pract | 1975 |
[Treatment of hyperlipemia. III. Practical modalities].
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Heparin; Humans; Hyperlipidemias; Nicotinic Acids; Thyr | 1975 |
Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
Topics: Adult; Blood Platelets; Cell Survival; Cholesterol; Clofibrate; Coronary Disease; Humans; Hyperlipid | 1975 |
Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
Topics: Animals; Body Weight; Butyrates; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Eva | 1975 |
[Mechanism of action of drugs affecting lipid metabolism].
Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; H | 1975 |
[Drug therapy of dyslipidemias].
Topics: Anticholesteremic Agents; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Heparin; Humans; H | 1975 |
[Treatment of hypercholesteremia].
Topics: Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Resins, Pla | 1975 |
The hyperlipoproteinemias in adolescence.
Topics: Adolescent; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Dietary Carbohydrates; Dietary F | 1975 |
[Diet and drug therapy of hyperlipoproteinemia].
Topics: Butyrates; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dietary Fats; Humans; Hyperlipidemias; | 1975 |
[Long-term treatment of hyperlipidemia (apropos of 32 cases observed for 6-36 months)].
Topics: Adult; Cholesterol; Clofibrate; Female; Follow-Up Studies; Humans; Hyperlipidemias; Male; Middle Age | 1975 |
Plasma squalene as an index of cholesterol synthesis.
Topics: Adult; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Humans; Hypercholesterolemia; Hype | 1975 |
[Treatment of hyperlipidemias by RU 19,583 (Dabical)].
Topics: Adult; Aged; Calcium; Clofibrate; Female; Humans; Hyperlipidemias; Male; Middle Aged | 1975 |
[Long-term management of various hyperlipidemias using clofibrate].
Topics: Adult; Aged; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Male; Middle Aged; Triglyceri | 1975 |
[Clofibrate and carbohydrate metabolism: behavior of blood insulin in patients with blood lipid disorders].
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Blood Glucose; Carbohydrate Metabolism; Clofibrate; Fema | 1975 |
New alpha-substituted arylthioacetic derivatives forming analogues of clofibrate.
Topics: Animals; Butyrates; Clofibrate; Hyperlipidemias; Magnetic Resonance Spectroscopy; Male; Nafenopin; R | 1975 |
[Reduction of serum triglycerides with a combined application of butylbiguanide and clofibrate in animal experiments].
Topics: Animals; Biguanides; Buformin; Clofibrate; Depression, Chemical; Drug Interactions; Fructose; Hyperl | 1975 |
[Indications for lipid reducing drugs].
Topics: Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Triglycerides | 1976 |
[Clinical experimentation with RU 19,(83 (Dabical) calcium clofibrate].
Topics: Adult; Calcium; Clofibrate; Drug Evaluation; Female; Humans; Hyperlipidemias; Male; Middle Aged | 1976 |
[From the Adverse Drug Reaction Committee: clofibrate and biliary tract calculi].
Topics: Angina Pectoris; Clofibrate; Female; Gallstones; Humans; Hyperlipidemias; Male | 1976 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine | 1976 |
[Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
Topics: Cholestyramine Resin; Clofibrate; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipidem | 1976 |
[Effect of clofibrate on unsaturated fatty acids in lipid fractions of sera in patients with hyperlipemia].
Topics: Adult; Aged; Clofibrate; Fatty Acids, Unsaturated; Humans; Hyperlipidemias; Middle Aged | 1976 |
Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model.
Topics: Animals; Benzofurans; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Magnetic Resonance Spectros | 1976 |
[Letter: Clofibrate and clofibrate-inositolnicotinate].
Topics: Clofibrate; Drug Combinations; Hyperlipidemias; Inositol; Nicotinic Acids | 1976 |
[Treatment of hyperlipidemia].
Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dieta | 1992 |
Should clofibrate still be prescribed?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Clofibrate; Humans; Hyperlipidemias | 1992 |
Independence of myocardial disease in the JCR:LA-corpulent rat on plasma cholesterol concentration.
Topics: Animals; Apolipoproteins; Arteriosclerosis; Blood Glucose; Cardiomyopathies; Cholesterol; Clofibrate | 1991 |
Lack of effect in vivo of clofibrate on adrenal steroid secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; | 1989 |
Apolipoprotein E variation in patients with hyperlipidaemia: DNA and protein phenotyping.
Topics: Adult; Apolipoproteins E; Clofibrate; DNA-Directed DNA Polymerase; Female; Genotype; Homozygote; Hum | 1989 |
Propylthiouracil-induced hypothyroid hyperlipidemic chick: a model for clofibrate-induced toxicity.
Topics: Animals; Chickens; Clofibrate; Hyperlipidemias; Hypothyroidism; Male; Muscles; Propylthiouracil | 1986 |
Yellow papules on a middle-aged woman. Eruptive xanthomatosis (EX).
Topics: Biopsy; Clofibrate; Dietary Fats; Female; Humans; Hyperlipidemias; Middle Aged; Skin Diseases; Trigl | 1989 |
[Xanthine compounds with anti-arteriosclerotic effect in rabbits].
Topics: Animals; Arteriosclerosis; Clofibrate; Drug Evaluation, Preclinical; Female; Hyperlipidemias; Hypoli | 1987 |
Effects of clofibrate on hyperlipidemia induced by polychlorinated biphenyls and elimination of polychlorinated biphenyls accumulated in rat tissues.
Topics: Animals; Clofibrate; Hyperlipidemias; Male; Polychlorinated Biphenyls; Rats; Rats, Inbred Strains | 1986 |
[Clinical and experimental study of Typha angustata on hyperlipoidemia].
Topics: Adult; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Medicine, Chinese Tr | 1985 |
[Leg blood supply in patients with arteriosclerosis obliterans and primary disorders of lipid metabolism after hypolipemic treatment].
Topics: Arteriosclerosis Obliterans; Clofibrate; Dietary Fats; Humans; Hyperlipidemias; Leg; Middle Aged; Re | 1988 |
Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
Topics: Animals; Apolipoproteins; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Fibric Acids; Hyperl | 1988 |
Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
Topics: Animals; Cholesterol; Clofibrate; Clofibric Acid; Disease Models, Animal; Glomerulonephritis; Glomer | 1988 |
Erythema multiforme due to clofibrate.
Topics: Aged; Clofibrate; Erythema Multiforme; Female; Humans; Hyperlipidemias; Hypertension | 1988 |
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
Topics: Albuminuria; Animals; Cholesterol; Clofibrate; Glomerulonephritis; Glomerulosclerosis, Focal Segment | 1988 |
[Strains and species differences in experimental hyperlipidemia].
Topics: Animals; Clofibrate; Disease Models, Animal; Gemfibrozil; Glycerides; Hyperlipidemias; Hypolipidemic | 1986 |
Medical management of hyperlipidemia and the role of probucol.
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gem | 1986 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Co | 1987 |
Adverse effects of the treatment for hyperlipidemia.
Topics: Anion Exchange Resins; Anticholesteremic Agents; Bibliographies as Topic; Clofibrate; Diet; Drug The | 1986 |
[Effect of silymarin on serum lipoproteins in hyperlipemic rats].
Topics: Animals; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Flavonoids; Hyperlipidemias; Lipoproteins, | 1987 |
[Drugs in hyperlipidemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemi | 1987 |
Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.
Topics: Adult; Aged; Apolipoproteins E; Cholesterol; Cholesterol, VLDL; Clofibrate; Diseases in Twins; Femal | 1985 |
Effects of tiadenol and clofibrate on plasma post heparin lipolytic hepatic, extrahepatic and monoglyceride hydrolase activities in rats with hypertriglyceridemia induced by a sucrose rich diet.
Topics: Animals; Clofibrate; Fatty Alcohols; Heparin; Hyperlipidemias; Lipase; Lipolysis; Lipoprotein Lipase | 1985 |
Plasma carnitine and lipid-lowering drugs.
Topics: Carnitine; Cholesterol, HDL; Clofibrate; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlip | 1985 |
Hyperlipidemic dementia.
Topics: Clofibrate; Dementia; Female; Fenofibrate; Humans; Hyperlipidemias; Middle Aged | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyr | 1985 |
Effect of probucol on triton induced hyperlipidemias in CFY rats.
Topics: Animals; Cholesterol; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Male; Phenols; Polyethylene | 1985 |
[New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity].
Topics: Animals; Chemical Phenomena; Chemistry; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Male; Mic | 1985 |
Chlorophenoxyisobutyric acid derivatives and apolipoprotein B metabolism.
Topics: Apolipoproteins B; Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipids; Lipoproteins; Triglycer | 1985 |
Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.
Topics: Adult; Binding Sites; Blood Protein Disorders; Clofibrate; Female; Fructose-Bisphosphate Aldolase; H | 1972 |
Cholesterol metabolism.
Topics: Arteriosclerosis; Cholesterol; Clofibrate; Genotype; Humans; Hyperlipidemias; Lipoproteins; Nicotini | 1973 |
Premature contractions and clofibrate.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clofibrate; Heart; Humans; Hyperlipidemias; Male | 1973 |
[Familial idiopathic hyperlipemis: diagnostic and therapeutic considerations].
Topics: Clofibrate; Diet Therapy; Heparin; Humans; Hyperlipidemias; Infant; Lipotropic Agents; Male; Thyroid | 1974 |
[Results of long-term treatment of hyperlipemias].
Topics: Adult; Aged; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins; Long-Term Care; | 1973 |
[Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
Topics: Blood Glucose; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins; Long-Term Car | 1973 |
[Therapeutic correction of hereditary idiopathic hyperlipemia. Evaluation of a standard diet].
Topics: Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Long-Term Care; Methods | 1973 |
New frontiers in paediatrics. Looking at handicapped children today.
Topics: Affective Symptoms; Anxiety; Child Care; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy | 1971 |
[Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study].
Topics: Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Male; Niacinamide; Nicotinic Acids; P | 1974 |
Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats.
Topics: Animals; Carbon Isotopes; Clofibrate; Depression, Chemical; Dietary Carbohydrates; Hyperlipidemias; | 1972 |
Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
Topics: Adult; Blood Protein Electrophoresis; Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; | 1972 |
Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
Topics: Adolescent; Adult; Angina Pectoris; Body Weight; Cholesterol; Clofibrate; Coronary Disease; Female; | 1972 |
Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
Topics: Adult; Aged; Cholesterol; Clofibrate; Coronary Disease; Fatty Acids; Female; Glycerol; Heparin; Huma | 1972 |
The relationship between insulin secretion and triglyceride concentration in endogenous lipemia.
Topics: Adult; Blood Protein Electrophoresis; Clofibrate; Diazoxide; Female; Glucose Tolerance Test; Humans; | 1973 |
[Xanthomatosis as a symptom of hyperlipidemic metabolic disorders. Relationship of the morphological picture to the lipid of three patients].
Topics: Adult; Arterial Occlusive Diseases; Blood Protein Electrophoresis; Cholestyramine Resin; Chylomicron | 1972 |
Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.
Topics: Abdomen; Acetoacetates; Administration, Oral; Adult; Amino Acids; Blood Glucose; Cholesterol; Clofib | 1973 |
Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Blood Protein Disorders; Body Weight; Cholesterol; C | 1973 |
[Drugs which influence plasma fatty acids and lipoproteins. Opinion of Prof. Rodolfo Paoletti].
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Clofibrate; Estrogens; Fatty Acids, Nonesterified; Fema | 1973 |
Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
Topics: Adult; Chlorpropamide; Cholesterol; Clofibrate; Diabetes Mellitus; Dietary Carbohydrates; Female; Ge | 1974 |
Comparative treatment of hyperlipoproteinaemias in chimpanzees.
Topics: Animals; Cholesterol; Clofibrate; Diet, Atherogenic; Fatty Acids; Female; Hyperlipidemias; Lipoprote | 1974 |
Viral infection and lipemia: a problem of disordered host physiology.
Topics: Animals; Carbon Dioxide; Chick Embryo; Clofibrate; Disease Models, Animal; Encephalitis; Encephaliti | 1974 |
Altering lipid patterns in adult males.
Topics: Adult; Aged; Blood Protein Electrophoresis; Cholesterol; Chylomicrons; Clofibrate; Coronary Disease; | 1974 |
[Treatment of hyperlipoproteinemias (author's transl)].
Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxin | 1974 |
Effect of Al-chlorophenoxyisobutyrate (Alufibrate) on pyruvate metabolism and on the fate of very low density lipoprotein lipids in hyperlipidemic patients.
Topics: Adult; Aluminum; Butyrates; Carbon Dioxide; Carbon Radioisotopes; Cholesterol; Clofibrate; Electroph | 1974 |
[Clofibrate in diabetes insipidus (author's transl)].
Topics: Adult; Clofibrate; Diabetes Insipidus; Diet; Humans; Hyperlipidemias; Lipoproteins, VLDL; Male; Sodi | 1974 |
[Current trends in the therapy of arteriosclerotic disease].
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Chylomicrons; Clofibrate; Female; Humans; Hyperlipidemia | 1974 |
Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia.
Topics: Adenosine Diphosphate; Arteriosclerosis; Blood Platelets; Carbon Radioisotopes; Clofibrate; Collagen | 1974 |
Xanthomatosis and hyperlipoproteinemia; a review.
Topics: Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet, Reducing; D | 1974 |
[Current position in the treatment of arteriosclerosis].
Topics: Arteriosclerosis; Clofibrate; Diabetic Angiopathies; Diet Therapy; Humans; Hypercholesterolemia; Hyp | 1974 |
[Pharmacological treatment of hyperlipoproteinemias--theory and practice].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Lipids; Lipoproteins; Nicotinic Acids | 1974 |
[Primary hyperlipoproteinemia of type V].
Topics: Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged | 1974 |
[Effect of a new lipid-reducing preparation in case of hyperlipoproteinemia].
Topics: Blood Chemical Analysis; Clofibrate; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids | 1974 |
The influence of drugs affecting lipids on atherosclerosis.
Topics: Adult; Arteriosclerosis; Blood Protein Disorders; Clofibrate; Coronary Disease; Diabetes Complicatio | 1974 |
Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.
Topics: Adolescent; Adult; Alkenes; Blood Pressure; Butyrates; Cholesterol; Cholestyramine Resin; Clofibrate | 1974 |
Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals.
Topics: Animals; Carboxylic Acids; Cholesterol; Clofibrate; Cyclohexanes; Dose-Response Relationship, Drug; | 1974 |
[Contribution to the study of mixed hyperlipidemias (type II b or VI). Apropos of 81 observations].
Topics: Clofibrate; Diet Therapy; Humans; Hyperlipidemias | 1974 |
[Therapeutic approach to a primary hyperlipemia].
Topics: Clofibrate; Hyperlipidemias | 1974 |
[Diagnosis and treatment of risk factors in chronic ischemic heart disease].
Topics: Adult; Age Factors; Arteriosclerosis; Cholestyramine Resin; Chronic Disease; Clofibrate; Coronary Di | 1974 |
[Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].
Topics: Adult; Blood Glucose; Carbohydrate Metabolism, Inborn Errors; Clofibrate; Diabetes Complications; Di | 1974 |
[Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Body Weight; Cholesterol; Clofibrate; Depressio | 1974 |
[Androgens, anabolic steroids and lipid metabolism].
Topics: Adult; Anabolic Agents; Androgens; Androsterone; Cholesterol; Clofibrate; Ethylestrenol; Female; Hum | 1972 |
Corrective therapy of atherogenic hyperlipemia.
Topics: Animals; Arteriosclerosis; Cholestyramine Resin; Clofibrate; Diet Therapy; Hyperlipidemias; Nicotini | 1972 |
[Hyperlipemia in flying personnel (civil aviation)].
Topics: Aerospace Medicine; Belgium; Cholesterol; Clofibrate; Fibrinogen; Humans; Hyperlipidemias; Phospholi | 1972 |
[What is assured in the treatment of hyperlipemia?].
Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine; | 1972 |
[Prevention of arteriosclerosis].
Topics: Adult; Arteriosclerosis; Clofibrate; Germany, West; Gout; Humans; Hyperlipidemias; Male; Middle Aged | 1973 |
[Index of "unbound" thyroxine in patients with hypercholesterolemia or hypertriglyceridemia treated with clofibrate].
Topics: Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Thyroxine; Thy | 1972 |
[Effect of chlorfibrinic acid on the triglyceride and glycogen contents of human liver as well as on blood-level forming metabolites].
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; | 1972 |
The hyperlipidaemias--a rational approach to classification and management.
Topics: Cholesterol; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hyperlipidemias; Nicotinic Acids; Tr | 1972 |
[Classification and treatment of hyperlipidemia: normolipemic treatments in 1972].
Topics: Aluminum; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides; Xanthomatosis | 1972 |
Do fats matter.
Topics: Arteries; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Coronary Di | 1972 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1973.
Topics: Acute Disease; Adult; Arteriosclerosis; Blood Protein Disorders; Cholecystitis; Cholelithiasis; Chro | 1973 |
[Treatment of hyperlipidemia].
Topics: Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids | 1973 |
[Drugs which decrease serum lipids].
Topics: Clofibrate; Depression, Chemical; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Nicotinic A | 1973 |
[Clofibrate and ischemic heart disease].
Topics: Clofibrate; Coronary Disease; Humans; Hyperlipidemias | 1973 |
[Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
Topics: Adult; Cholesterol; Clofibrate; Dipyridamole; Drug Synergism; Humans; Hyperlipidemias; Male; Middle | 1973 |
[Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
Topics: Adult; Arteriosclerosis; Cholesterol; Clofibrate; Glomerulonephritis; Humans; Hyperlipidemias; Male; | 1973 |
[Hypolipemic agents].
Topics: Androgens; Biological Transport; Butyrates; Cholestyramine Resin; Clofibrate; Estrogens; Fatty Acids | 1973 |
Reversibility of lipid deposition.
Topics: Arteriosclerosis; Cholesterol; Clofibrate; Cornea; Coronary Disease; Coronary Vessels; Evaluation St | 1973 |
[Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
Topics: Arteriosclerosis; Clofibrate; Fatty Alcohols; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; | 1973 |
Growth hormone secretion in primary endogenous hypertriglyceridemia.
Topics: Adult; Arginine; Blood Glucose; Body Weight; Clofibrate; Fatty Acids, Nonesterified; Female; Glucago | 1973 |
Atheromatous plaques of the retinal blood vessels. Histologic confirmation of ophthalmoscopically visible lesions.
Topics: Arteriosclerosis; Autopsy; Clofibrate; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Male; | 1973 |
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Electropho | 1973 |
[Recent concepts of arteriosclerosis, studied in correlation with the classification of hyperlipoproteinemia and the indicated laboratory methods].
Topics: Arteriosclerosis; Carbohydrate Metabolism; Clofibrate; Humans; Hyperlipidemias; Lipid Metabolism; Li | 1973 |
Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.
Topics: Animals; Anticholesteremic Agents; Benzene Derivatives; Benzofurans; Benzopyrans; Carboxylic Acids; | 1973 |
[Does magnesium-orotate improve the effect of lipid lowering drugs?].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Body Weight; Cholesterol; Clofibra | 1973 |
Serum cholesterol and triglycerides.
Topics: Adolescent; Adult; Age Factors; Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins; Midd | 1973 |
[Case of primary hyperlipemia treated with cynarin].
Topics: Cinnamates; Clofibrate; Cyclohexanecarboxylic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Xan | 1973 |
The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
Topics: Adult; Anticholesteremic Agents; Body Weight; Carbon Isotopes; Cholesterol; Clofibrate; Drug Synergi | 1973 |
Editorial: Diet and drugs for hyperlipidaemia.
Topics: Body Height; Body Weight; Clofibrate; Diet; Humans; Hyperlipidemias; Patient Care Planning; Vascular | 1973 |
[Therapeutic results in directed and nondirected therapy of hyperlipoproteinemia].
Topics: Blood Protein Disorders; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoproteins | 1973 |
[Hyperlipoproteinemia type 3. Report on 5 cases].
Topics: Adult; Blood Protein Electrophoresis; Body Weight; Cholesterol; Clofibrate; Diagnosis, Differential; | 1973 |
The effect of clofibrate on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV.
Topics: Adult; Aged; Carbon Radioisotopes; Chenodeoxycholic Acid; Cholesterol; Cholic Acids; Clofibrate; Fem | 1973 |
Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
Topics: Adolescent; Adult; Alcohol Drinking; Body Weight; Child; Cholesterol, Dietary; Cholestyramine Resin; | 1973 |
Effect of combined administration of clofibrate and neomycin on serum cholesterol levels in familial type II hyperlipoproteinaemia.
Topics: Adolescent; Adult; Child; Cholesterol; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyperl | 1973 |
[Current clinical aspects of primary hyperlipemia].
Topics: Anabolic Agents; Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Nicotinic Acids; Termino | 1973 |
Clinical studies concerning factor XIII; with special reference to hyperlipemia.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Arteriosclerosis; Blood Cell Count; Blood Coagulation | 1973 |
[Pyridoxine para-chloro-phenoxy-isobutyrate. Analysis of hypolipidemic effects].
Topics: Clofibrate; Diabetes Mellitus; Diet; Drug Evaluation; Humans; Hyperlipidemias; Obesity; Pyridoxine; | 1973 |
[Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoproteins; | 1973 |
[Ambulatory treatment of hyperlipemias].
Topics: Ambulatory Care; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Nicotinic | 1973 |
[Biguanide therapy of primary hyperlipoproteinemias type IIb, 3 and IV as monotherapy and combined with clofibrate].
Topics: Adult; Aged; Biguanides; Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Middle Aged; Phenfo | 1973 |
[Clinical experimentation of clofibride. Apropos of 40 cases].
Topics: Adult; Amides; Clofibrate; Diet; Drug Evaluation; Drug Interactions; Female; Humans; Hypercholestero | 1973 |
[Effect of short-term treatment with chlorophenoxyisobutyrate on serum lipids and pseudocholinesterase and plasmatic fibrinogen in hyperlipemic patients].
Topics: Adult; Butyrylcholinesterase; Cholinesterases; Clofibrate; Female; Fibrinogen; Humans; Hyperlipidemi | 1973 |
Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Topics: Adult; Aged; Antigens; Blood Glucose; Blood Protein Disorders; Body Weight; Clofibrate; Fatty Acids, | 1974 |
Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
Topics: Bile; Bile Acids and Salts; Carbon Radioisotopes; Cholecystectomy; Cholecystography; Cholelithiasis; | 1974 |
A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia.
Topics: Abdomen; Adult; Cholesterol; Chylomicrons; Clofibrate; Diabetes Complications; Diet, Reducing; Elect | 1974 |
Hyperlipidemic dementia.
Topics: Cholesterol; Clofibrate; Dementia; Diabetes Complications; Diabetes Mellitus; Diet Therapy; Diet, Di | 1974 |
The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia.
Topics: Adult; Biological Transport; Clofibrate; Fatty Acids, Nonesterified; Female; Fructose; Humans; Hyper | 1974 |
[Limits in Frederickson's classification in the typization of human hyperlipoproteinemias. Personal experience].
Topics: Blood Protein Electrophoresis; Cholesterol; Clofibrate; Diet Therapy; Dietary Fats; Electrophoresis, | 1974 |
Platelet survival time in angina pectoris and hyperlipoproteinaemia.
Topics: Angina Pectoris; Blood Platelets; Blood Protein Disorders; Cell Survival; Chromium Radioisotopes; Cl | 1974 |
[Incidence of hyperlipoproteinemias, their classification and influencing through diet during a course of spa treatment. II. Clinical part].
Topics: Adult; Balneology; Cholestyramine Resin; Clofibrate; Czechoslovakia; Diet Therapy; Female; Health Re | 1974 |
[Multiple aseptic bone necrosis in hyperlipidaemia, hyperuricaemia, and latent diabetes mellitus (author's transl)].
Topics: Adult; Allopurinol; Bone Diseases; Clofibrate; Diet Therapy; Dietary Carbohydrates; Femur Head Necro | 1974 |
[Therapeutic effect of clofibrate in a patient with primary hyperlipoproteinemia type 3].
Topics: Clofibrate; Evaluation Studies as Topic; Female; Humans; Hyperlipidemias; Lipoproteins; Middle Aged | 1974 |
[Studies on hypolipidemic agents. I. Syntheses and hypolipidemic activities of 2-(4'-chlorophenoxy)isobutyric acid derivatives (author's transl)].
Topics: Animals; Anticholesteremic Agents; Clofibrate; Hyperlipidemias; Male; Rats | 1974 |
[Hyperlipoproteinemias: significance--diagnosis--therapy].
Topics: Adolescent; Adult; Blood Protein Disorders; Cardiovascular Diseases; Child; Child, Preschool; Choles | 1971 |
Long-term treatment of hyperlipidemic patients with clofibrate.
Topics: Adult; Aged; Body Weight; Cholesterol; Clofibrate; Female; Glucose; Glucose Tolerance Test; Humans; | 1971 |
Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver.
Topics: Adolescent; Adult; Alcoholism; Blood Glucose; Carbon Isotopes; Clofibrate; Dietary Carbohydrates; Fa | 1972 |
[Therapy of essential hyperlipidemias].
Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbohydrates; Humans; Hyperlipidemias; Nico | 1972 |
Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
Topics: Animals; Carboxylic Acids; Cholesterol; Clofibrate; Disease Models, Animal; Fasting; Hyperlipidemias | 1972 |
Type IV hyperlipoproteinemia in a consanguinous family.
Topics: Adult; Aged; Allopurinol; Clofibrate; Consanguinity; Dietary Carbohydrates; Female; Glucose Toleranc | 1972 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Die | 1972 |
Lipid lowering agents.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; H | 1972 |
Confusion with clofibrate.
Topics: Clofibrate; Humans; Hyperlipidemias; Lipid Metabolism; Platelet Adhesiveness | 1972 |
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Carbon Isotopes; Child; Cholesterol; Cholestyramine Resin; | 1972 |
[Treatment of hyperlipidemia in patients with ischemic heart disease].
Topics: Clofibrate; Coronary Disease; Female; Heparin; Humans; Hyperlipidemias; Lipid Metabolism; Male; Midd | 1972 |
Hyperlipoproteinemia. 3. Drug therapy.
Topics: Age Factors; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Ethers, Cyclic; Humans; H | 1972 |
[Therapy of primary hyperlipidemias].
Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemi | 1972 |
Clofibrate and nicotinic acid.
Topics: Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipids; Nicotinic Acids | 1972 |
Lack of degradation of dietary and endogenous sterols in gastrointestinal tract of man.
Topics: Adult; Angina Pectoris; Cholesterol; Clofibrate; Coronary Disease; Diet; Digestive System; Feces; Fe | 1972 |
[The clinical and biochemical aspects of clofibrate].
Topics: Animals; Arteriosclerosis; Chemical Phenomena; Chemistry; Clofibrate; Coronary Disease; Diabetic Ret | 1972 |
Drug treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Trigl | 1972 |
Primary prevention of atherosclerotic cardiovascular disease among Sabena flying personnel.
Topics: Aerospace Medicine; Arteriosclerosis; Cardiovascular Diseases; Clofibrate; Humans; Hypercholesterole | 1972 |
[Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia].
Topics: Adult; Arteriosclerosis; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipids; Male; Mid | 1972 |
The treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Estrogens; Humans; Hyperlipidemias; | 1972 |
[Serum cholesterol and total serum lipids of psoriasis patients in comparison with healthy persons and other diseases].
Topics: Adolescent; Adult; Aged; Child; Cholesterol; Clofibrate; Eczema; Female; Humans; Hyperlipidemias; Li | 1972 |
[Treatment of hyperlipoproteinemia in relation to recent classifications].
Topics: Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Thyroid Ho | 1971 |
[Results and prospects of the use of drugs acting on serum lipoproteins in atherosclerosis].
Topics: Arteriosclerosis; Clofibrate; Glycolates; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoprotein | 1971 |
Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia.
Topics: Adult; Blood Glucose; Body Weight; Clofibrate; Dietary Carbohydrates; Fatty Acids, Nonesterified; Gl | 1971 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes M | 1971 |
Treatment of familial hypercholesterolemia in children.
Topics: Adolescent; Arteriosclerosis; Body Weight; Child; Child, Preschool; Cholesterol; Clofibrate; Diet Th | 1971 |
[Fat-induced hyperlipoproteinemia and lipiduria in a small child].
Topics: Aminohippuric Acids; Blood Protein Disorders; Child, Preschool; Clofibrate; Dietary Fats; Heparin; H | 1971 |
Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
Topics: Adult; Blood Glucose; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Fasting; F | 1971 |
[Effect of Clofibrate on disorders in lipid metabolism. I].
Topics: Adult; Aged; Clofibrate; Drug Tolerance; Evaluation Studies as Topic; Female; Humans; Hyperlipidemia | 1971 |
[Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Female; Humans; Hyperlipidemias; Lipid Metabolism; Lipids | 1971 |
[Primary hyperlipoproteinemia. IV. Treatment].
Topics: Adult; Blood Protein Disorders; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoproteins; Mid | 1971 |
[Antilipidemic agents].
Topics: Adult; Alcohols; Anticholesteremic Agents; Biguanides; Blood Protein Disorders; Body Weight; Cholest | 1971 |
[Hyperlipemic conditions: results of their treatment with clofibrate-methandrostenolone].
Topics: Adult; Aged; Clofibrate; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; Lipids; Male; Methandr | 1971 |
Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
Topics: Adult; Aged; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; | 1971 |
[Therapy of hyperlipidemias].
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Estrogens; Glycine max; Heparin; Humans; Hyperlipidem | 1971 |
Human plasma fatty acid composition: the features of hyperlipoproteinemia and the influence of -linolenate and clofibrate.
Topics: Adult; Aged; Blood Protein Disorders; Cholesterol; Clofibrate; Diabetes Mellitus; Fatty Acids; Fatty | 1971 |
[Diagnosis and therapy of familial hyper- -lipoproteinemia (familial hypercholesterolemia or familial hyperlipoproteinemia of type II)].
Topics: Adolescent; Cholestyramine Resin; Clofibrate; Dextrans; Diet Therapy; Female; Humans; Hypercholester | 1971 |
[New aspects of the therapy of arteriosclerosis].
Topics: Arteriosclerosis; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoprote | 1971 |
Drug treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Li | 1969 |
[Hyperlipiemia and its therapy by clofibrate].
Topics: Administration, Oral; Adult; Aged; Cholesterol; Clofibrate; Fatty Acids, Nonesterified; Female; Huma | 1969 |
Polyneuropathy associated with hyperlipemia.
Topics: Aged; Blood Glucose; Blood Protein Electrophoresis; Cholesterol; Chromatography, Thin Layer; Clofibr | 1969 |
[Treatment of essential hyperlipemia with clofibrate].
Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Fatty Acids, Essential; Fatty Acids, Nonesterifie | 1969 |
Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.
Topics: Adolescent; Adult; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Drug Synergi | 1970 |
[Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners].
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Family Practice; Humans; Hypercholesterolemia; Hyperlip | 1970 |
Cholesteryl ester turnover in human plasma lipoproteins during cholestyramine and clofibrate therapy.
Topics: Aged; Anticholesteremic Agents; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Clofibrate; Este | 1970 |
Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
Topics: Adolescent; Adult; Age Factors; Aged; Anticholesteremic Agents; Arteriosclerosis; Blood Glucose; Cho | 1970 |
Clofibrate.
Topics: Anticholesteremic Agents; Clofibrate; Humans; Hypercholesterolemia; Hyperglycemia; Hyperlipidemias; | 1970 |
Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
Topics: Adolescent; Adult; Aged; Body Weight; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Dextroth | 1970 |
[Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate].
Topics: Anticholesteremic Agents; Clofibrate; Female; Humans; Hyperlipidemias; Male; Propionates; Triglyceri | 1970 |
[Serum-lipid reducing principles--possibilities for treatment. 8. Diet and drug treatment].
Topics: Adult; Anticholesteremic Agents; Clofibrate; Diet Therapy; Follow-Up Studies; Humans; Hyperlipidemia | 1970 |
Diet and drugs in the treatment of hyperlipidemias.
Topics: Anticholesteremic Agents; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; H | 1970 |
[Unorthodox reflections about arteriosclerosis].
Topics: Animals; Arteriosclerosis; Cholesterol; Clofibrate; Heart Failure; Humans; Hypercholesterolemia; Hyp | 1970 |
Treatment of hyperlipidemia.
Topics: Anticholesteremic Agents; Clofibrate; Coronary Disease; Diet Therapy; Dietary Carbohydrates; Dietary | 1970 |
[Diagnosis and treatment of hyperlipoidaemias].
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyper | 1970 |
Angina pectoris--II.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cholesterol; Cholestyramine Resin; Clofibrate; D | 1971 |
Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.
Topics: Acetates; Anticholesteremic Agents; Bile; Carbon Isotopes; Cholesterol; Chromatography, Thin Layer; | 1971 |
Xanthomatosis, hyperlipoproteinaemia (type II, Fredrickson), gout, cardiac infarction.
Topics: Adult; Cholesterol; Clofibrate; Gout; Humans; Hyperlipidemias; Indomethacin; Lipoproteins; Male; Myo | 1971 |
Management of excess serum lipid.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Ileum; Neo | 1971 |
Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
Topics: Angina Pectoris; Blood Protein Disorders; Blood Protein Electrophoresis; Body Weight; Cholesterol; C | 1971 |
[Diagnosis and therapy of symptomatic and essential hyperlipidemia].
Topics: Cholestyramine Resin; Chromatography, Thin Layer; Clofibrate; Humans; Hyperlipidemias; Lipids; Lipop | 1971 |
[Treatment of hyperlipemias].
Topics: Cholesterol; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohydrates; Dietary Fats; | 1971 |
Diet and drug therapy for hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Body Weight; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbo | 1971 |
[Therapy of primary hyperlipemia].
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Diet, Reducing; | 1971 |
[Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
Topics: Blood Protein Electrophoresis; Cholesterol; Chylomicrons; Clofibrate; Humans; Hyperlipidemias; Lipop | 1971 |
[Arteriosclerosis--nicotinic acid therapy. 8. Treatment of hyperlipemia].
Topics: Cholesterol; Clofibrate; Diet Therapy; Esters; Female; Humans; Hyperlipidemias; Male; Nicotinic Acid | 1971 |
[Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Drug Synergism; Esters; Humans; Hyperlipidemias; | 1971 |
Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
Topics: Adenine Nucleotides; Adult; Aged; Anticholesteremic Agents; Blood Cell Count; Blood Platelets; Chole | 1971 |
[Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
Topics: Adult; Aged; Anticholesteremic Agents; Clofibrate; Diabetes Mellitus; Female; Humans; Hyperlipidemia | 1968 |
Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).
Topics: Adult; Aged; Angina Pectoris; Anticoagulants; Blood Coagulation Disorders; Clofibrate; Diabetic Neur | 1968 |